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1.1 SHORT DEFINITION OF RATIONALE OF THESIS 
Nowadays everybody has become familair with the procedure of blood trans-
fusion. It is not always appreciated, however, that transfusions are equivalent to 
transplantations. This latter term is commonly reserved for the more spectacular 
transplantations of kidney, liver or heart, in which an organ from a deceased 
individual is given to a living human patient in need of such an organ. 
It has become generally accepted that before blood of a given donor can be given 
to a particular patient investigations have to be done to exclude a possible 
harmful effect of the blood on the recipient. The impressive bloodbanking in-
stitutes all over the world are in themselves convincing examples of the impor~ 
lance of finding compatible blood for each individual patient. ln theory com-
patibility tests between donor and recipient would also seem to be indicated foi 
solid organ transplantations just as for tranfusions. In practice compatibility 
tests (or in other words donor selection) are not performed by all teams involved 
in transplantation in humans. Major reasons for this negative attitude towards 
donor selection for organ grafting are probably that l) it appears to be a com-
plicated art to the uninitiated and 2) no clear cut beneficial effect of donor 
selection could be demonstrated in some of the first clinical trials with human 
kidney transplantation (47, 53). However, in a number of other studies a favour-
able effect of donor selection has been found (28, 57, 94). 
The experimental studies described in this thesis were initiated with the purpose 
of obtaining a model in an outbred experimental animal, in which the doubts on 
the usefulness of donor selection for organ transplantation could be evaluated. 
1.1.1 Definition of histocompatibility 
Donor selection for organ transplantation is necessarily a study of genetics. 
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This statement can be illustrated by a compariso!l_of the survival of organs from 
donors, which differ in their genetic relationship with the recipient. 
If inbreeding is pursued for a sufficient number of generations, a population of 
individuals will be produced which are genetically speaking identical. This has 
been achieved in so-called "inbred strains" of mice and rats. Identical (or mono-
zygotic) human twins are another example of genetically speaking identical 
individuals. _Tissue transplanted between members of a inbred strain or between 
human identical twins will survive as long as the recipient. 
In other host donor combinations, where genetic differences do exist, the survival 
of a transplanted organ appears to be limited. It will initially be accepted, but 
gradually the recipient will by means of its immune system recognize the 
transplant as "foreign" and mount an attack against the donor tissue. This attack 
damages the transplant, which will loose its function and necrotize. The donor 
tissue is'then said to be "rejected" by the recipient. The difference in fate 
between a transplant from a monozygote twin and one from an unrelated 
individual demonstrates that the ultimate success or failure ("rejection") of a 
tissue graft is determined by differences in genetically controlled structures in 
donor and recipient. The genes controlling these structures have been called 
histocompatibility genes, since they determine whether tissue (histos in Greek) 
will be compatible with a given recipient. 
1.1.2 Rationale of choice of experimental animal 
Besides the genetic control of coat colours (chapter 4, reference 15) relatively 
little. is known of dog's genetics in comparison to the available knowledge in 
other domestic animals. The dog was nevertheless chosen as experimental animal 
for a genetic subject as donor selection because it is readily available, has a size 
attractive for transplantation surgeons and a temperament, which is suitable for 
an intensive post operative care. The dog has in fact been used in many 
transplantation experiments in the past but only rarely attempts have been made 
to define histocompatibility genes in this species (24, 25, 34, 37, 97). 
Another advantage of dogs is that mongrel dogs and also purely bred dogs (9la) 
can be considered to be outbred, which is a property in common with human 
populations. This will facilitate an extrapotation of experimentally obtained 
results to humans. The best model for this purpose is of course the outbred non 
human primate and in particular the chimpanzee: Extensive use of this species in 
the laboratory is, however. limited by the fear of extinction of the chimpanzee 
and by the biotechnical and financial problems involved. Among primates 
Rhesus monkeys are the most commonly used experimental animals and 
extensive studies of donor selection have been performed in this species (e.g. 
10). However, the shorter generation and gestation time of dogs offer better 
possibilities for family studies, which are an essential part of any genetic study. 
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Besides the interest in the role of genetics (or in other words histocompatibili-
ty) in the determination of organ graft survival, investigations have been started 
in several mammalian species to define other effects of histocompatibility 
structures. As will be discussed later (see 1.3.3), some preliminary evidence has 
been obtained that histocompatibility structures play a r6le in the determination 
of disease susceptibility. The dog might also be a useful experimental animal for 
this aspect of histocompatibility studies. It was probably the first animal to be 
domesticated by man (around 10,000 years B.C. (see (3) for references). The 
close physical proximity of man and dog from that time onwards made them 
share habitat, diet and exposure to other pathogens. Many human diseases occur 
also in dogs (chapter 5, reference 6). These diseases are ideal models for an 
experimental evaluation of a possible correlation between histocompatibility 
structures and disease susceptibility in dogs, since the obtained results might be 
very relevant for human patients, with the equivalent disease. 
1.1.3 Lay out of contents of this thesis 
The current use of histocompatibility testing in experimental biology and in 
human medicine can be seen as the logical sequel of advances in two different 
fields of research during the 20th century. A short survey of developments in 
both fields, i.e. I) transplantation of tumour cells and 2) the serological 
determination of individual differences, will be given in part 1.2 of this chapter. 
Part 1.3 classifies current topics in histocompatibility research. It also serves as 
an introduction to chapters 2-5 which represent work already published in 
scientific journals. They are reprinted in chronological order illustrating the 
successive steps taken in the past few years to gain more knowledge on canine 
histocompatibility. Chapter 6 is devoted to a discussion of the obtained results. 
In this chapter the conclusions which were reached on the basis of the described 
studies are listed. An appendix describing the micro-cytotoxicity test used, a 
summary in English and Dutch, acknowledgements and a curriculum vitae of the 
author constitute the last part of this thesis. 
1.2 IDSTORICAL SURVEY OF HISTOCOMPATIBILITY 
A survey of important developments of the past in the fields of tumour 
transplantation and immunogenetics gives an insight into the "why's" of 
histocompatibility. Both fields developed separately, but merged, when it 
appeared useful to determine prospectively differences between donor and 
recipient by serological methods. Only those aspects will be discussed here, 
which are relevant to the investigations described in the following chapters. 
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1.2.1 Transplantation of tumour cells 
Origin of interest in tumour transplantation 
M. Novinsky was probably the first (1876) to report a successful transplant of a 
piece of malignant tumour between individuals of one species. Incidently his 
experiments were performed with a medullary carcinoma in dogs (83). The 
interest of research workers in the beginning of this century in this type of 
experiments stemmed from their desire to prove or disprove the communicabili-
ty of malignant growth. Soon they noted that a successful "take" and 
subsequent growth of transplanted tumour material was not regularly achieved. 
Viable tumour cells seemed to be a prerequisite for a successful transplantation. 
The success rate, however, appeared to be very unpredictable when out bred 
animals were used. In mice, which were inbred for several generations, more 
consistent success or failure rates were achieved with tumour cell injections (54). 
The question whether cancer must be regarded as a special kind of infectious 
disease will not be further dealt with here, since it is outside the scope of this 
thesis. 
Genetic studies of tumor graft survival 
In 1916 Little and Tyzzer ( 69) reported on experiments especially designed 
to study genetic influences on the growth of a transplanted tumour in mice. They 
concluded that the recipient's susceptibility to the tumour is controlled by 
mendelian systems located on several chromosomes. Another illustration of the 
influence of genetics on the occurence of malignancies is the difference in 
susceptibility to transplanted or spontaneously occuring tumours in the available 
laboratory mouse strains. The existing strains of inbred mice, differ in their 
genetic background and all have their own spectrum of susceptibility or 
resistence to different malignancies (81). 
Comparison between transplantation of normal and malignant cells 
Some of the genetical systems which influence susceptibility to injected 
tumour cells appear to be of equal importance for the survival of normal cells. 
Gorer (43) and Medewar and co-workers (75) have been able to show that the 
rejection or acceptance of foreign tissue is determined by the immunological 
reactivity of the host against parts of the cell membrane ofthese foreign cells. Most 
of these parts are found on tumour cell as well as on normal cell membranes and 
are thus not exclusively limited to tumour cells. However, tumour specific 
membrane parts have been found (for review of this subject see (58)). They 
might play a rOle in the genetic control of tumour susceptibility, since some 
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individuals might be able to react immunologically against these tumour specific 
structures and thus to destroy the tumour, while other might not. These 
individual differences in immunological reactivity might well be genetically 
determined, since examples of a genetic control of immunological reactivity have 
been found (72). There is ample evidence for the involvement of the immune 
system of an individual in the determination of tumour susceptibility. The most 
striking examples are the higher frequency of malignancies in immunosuppressed 
animals (77) and human patients with iatrogenic or congenital immunodeficien-
ces (41. 74). A rapid further elucidation of this role of the immune system and 
the possible genetic factors behind it is evidently of great importance. Some of 
the existing theories on the possible role of histocompatibility in the genetic 
control of disease susceptibility will be discussed in the tlnal paragraph of this 
chapter. 
Those membrane parts, which normal and tumour cells have in common and 
which determine the survival of these cells, when transplanted to another 
individual, have already been introduced in the tlrst paragraph of this chapter, 
t.J.nder the name of histocompatibility structures. The genetic control of these 
structures have primarily been evaluated in transplantation experiments with 
murine tumours. ln the following paragraphs the results of these studies will be 
briefly summarized with the major emphasis on two points, 1) the number of 
different genetic systems which control histocompatibility structures and 2) the 
relative importance or strength of such structures. For detailed information and 
further references on these matters the reader is advised to consult the review of 
Snell and Stimpfling (101). 
The number of histocompatibility systems 
In the last decades most transplantation experiments using normal or 
malignant tissue have been performed in and between inbred strains of mice. 
Other mammalian species without the economical advantages of small rodents 
have been less well investigated. However, even in mice the overall picture of 
genes controlling graft survival is far from complete. Striking similarities in 
mammalian histocompatibility systems (H-systems) have been found so far (see 
tlg. 6.3). This warrants a further discussion of the available knowledge in the 
mouse. 
For a thorough analysis of the number of H-systems in a species a large 
number of offspring has to be raised from random individuals, following an 
especially designed pedigree. Numerous grafts exchanged between members of 
different generations have then to be done. A determination of the percentage of 
successful grafts in these experiments will allow an estimate of the number of 
H-systems present. Obviously economical reasons limit this approach to small 
animals with short generation times. Experiments performed by Snell in 1948 
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(100) demonstrated the existence of at least !3 H-systems located on 13 
different chromosomes in mice. Later experiments (23) have indicated that this 
number is probably an underestimate. 
The strengh of a histocompatibility system 
A difference between H-systems in a species appears to be the barrier which 
genes from different H-systems oppose to a transplant. Some of the barriers are 
more easily overcome than others. If mouse strain systems differ for genes of 
one particular genetic system, the H -2 system, grafts exchanged between them 
are rapidly rejected. The rejection pattern is not easily intluenced by immuno-
suppressive procedures. The H-2 system is said to be the "'strongest" or major 
histocompatibility system in mice. Differences in other H-systems do not lead to 
rejection as fast as an H-2 difference and are easier to overcome by immunosup-
pression. These systems have been labelled "weak" or minor histocompatibility 
systems. Graff et al. (44) demonstrated. however, ·that differences in minor 
histocompatibility systems can cumulate and that many incompatibilities for 
non H~2 systems can give rise to rejection times almost as short as when an H~2 
difference is involved. 
Tissue distribution of histocompatibility systems 
Major histocompatibility genes· are expressed on all cells of an individual 
except perhaps on the red cells of some mammalian species (50, 80). Some but 
~complete data are available on the tissue distribution of minor histocompati-
bility systems. Lance et al. (61a) have been able to show that in epidermal cells 
in mice genes are expressed of a system which was labelled SK. They are 
certainly not expressed in haemopoietic or lymphoid cell lines and presumably 
not in other tissues, besides epidermis. Differences in the SK system between 
donor and recipient cause rejection of skin grafts and have been· identified as a 
possible reason for the more violent and faster rejections of H-2 compatible skin 
grafts. when compared to other H-2 compatible tissues e.g. kidneys (99). The SK 
system has been called a system, controlling differentiation antigens, since it is 
only expressed in cells, which have differentiated in a certain way (as epidermal 
cells). Other differentiation systems are known in mice. e.g. Ly, TL, and El. They 
are of great importance in studies of fundamental immunology but will not be 
discussed here, since they have not been shown to have a histocompatibility 
effect. The division of H-systems into one major and an as of yet undetermined 
number of minor histocompatibility systems has appeared to be realistic for all 
mammalian species so far investigated. Man(!), rhesus monkey (10, 40), rabbit 
(106), pig (107), dog (this thesis), rat (87) and guinea pig (109). 
When the data given in 1.2 .1 are briefly summarized, it is . clear that the 
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transplantation of tumour cells demonstrated the existence of genetic structures 
on mammalian cells, which are also occuring on normal cells. These structures 
determine the survival time of these cells in another individual. The next 
paragraph will describe the gradual development of methods for an in vitro 
identification of the products of genetic systems, which have a major influence 
on graft survival.. 
1.2.2 Serological determination of individual differences 
Around 1900 Landsteiner ( 62) started his classical studies on properties of 
human red cells, controlled by the ABO system. Antibodies against antigens of 
the ABO system were found to be present in sera of normal unimmunized 
adults. After Landsteiner's experiments with these so-called "naturally occuring" 
antibodies, experiments were started by him and others, ~n which immunizations 
with blood or blood components between individuals of the same or different 
species were carried out. As expected these immunizations were found to give 
rise to antibodies against the cells used for immunizations. More important was 
the observation that such antisera also reacted with some but not all of the cell 
samples of other individuals from the same species as the donor used for 
immunizations. Soon the hypothesis was formulated that the structure on the 
cell, which reacted with the antiserum, was genetically determined. Therefore 
genetic tests have been applied to the results obtained with the produced 
antisera. The next paragraph will discuss this kind of analysis briefly. 
Population and family studies of immunogenetic systems. Application of laws of 
Mendel and Hardy Weinberg. 
If one wants ~o determine whether a factor recognized by a particular 
antiserum is genetically determined, the occurence of this factor has to be 
studied in populations of unrelated individuals and in families. For the ease of 
the argument it will be assumed. that the antiserum under study contains 
antibodies against one factor only, although this is the exception rather than the 
rule after immunizations in unselected donor-recipient pairs. The analysis of sera 
with antibOdies against more than one factor is more complicated and will not 
be discussed here (see 1.3.1 ). If many different immunizations are done, antisera 
against one factor only, .so called "monospecific" antisera will be produced in at 
least some of the recipients. If such sera recognize a factor which is controlled 
by a gene from one genetic system, other gene(s) must"exist for the same s)rstem, 
since some of the individuals do not carry the factor (are negative with the 
produced antisera). The term polymorphism has been applied to those genetic 
systems in which at least two alternative forms or genes (allelomorphs or alleles 
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for short) exist. When it is assumed that a genetic system exists, which is located 
on a particular area (locus) of chromosome and that different (two or more) 
forms of genetical information (allelic genes) can to the exclusion of each other 
occupy that area, the law of Mendel will predict the behaviour of the alleles in 
families. In general a parent, which carries alleles A and B, of one polymorphic 
system, has an equal chance of 0.5 to pass on A or B to his offspring. In 
reference 14 of chapter 3 examples and methods are given to test family data for 
concordance with Mendel's law. The distribution of alleles in a population of 
unrelated individuals can be predicted by the law of Hardy-Weinberg (for 
examples see (68)). According to this law two alleles P and Q will under normal 
conditions be distributed in unrelated individuals following their relative fre~ 
quencies (p and q, p + q = 1). A p2 fraction of individuals will have allele Pin a 
double dose (=homozygous for P), a 2 pq fraction will have P and Q 
(= heterozygotes) and finally a q2 fraction of all individuals will have Q in a 
double dose(= homozygotes for Q). 
Thus the patterns found with antisera in families and populations can be 
tested for accordance with expectations based on the laws of Mendel and 
Hardy-Weinberg. Statistical procedures will measure the significance level of the 
found deviations from the expected ones. If non-significant levels (for example 
p;:;, 0.1) are found, the studied antibodies recognize probably factors controlled 
by alleles of one genetic system. Numerous genetic systems with multiple alleles, 
controlling factors of erythrocytes, leucocytes, platelets and serum proteins have 
been discovered in many different species by the use of the methods just 
described. The specificity of the immune response was thus proven to be a very 
useful tool for the recognition of some genetic polymorphisms. Irwin was the 
first to use the term immunogenetics for this kind of research activity. 
In summary the described approach indicates that for a polymorphic genetic 
system one can attempt to read the formula gene-+ factor (antigen)-+ antibody 
backwards, i.e. starting at the antibody end (51), after the production of 
appropriate antisera. 
Use of serological techniques for histocompatibility testing 
Landsteiner (63) in his Nobel lecture in 1931 clearly indicated the potential 
value of serologically determined differences between individuals as indices of 
compatibility for transplantation. The results obtained in clinical skingrafting 
were, however, still very unpredictable in those days. Gorer in 1938 (43) was the 
first to demonstrate successfully how to bridge the gap between the already 
known genetic control of histocompatibility and the ignorance of how to 
determine these genetical tracts in vitro. In serological tests with a rabbit anti 
mouse serum he found evidence for the existence of an antigen common to cells 
of a certain mouse tumour and erythrocytes of some mouse strains. The tumour 
16 
was rejected by animals lacking the antigen on their erythrocytes, while it grew 
in animals carrying the antigen. Thus histocompatibility genes seemed to be 
amenable to analysis by the determination of their end products, antigens, on the 
cell membrane. To avoid confusion it should be stressed that only some of the 
systems, which have been identified by immunogenetical methods, appear to 
have an effect on organgraft survival of genetically different donors. Many of the 
immunogenetic systems found do not have such a histocompatibility effect. 
Furthermore these data underline the earlier made remark that some genetically 
controlled factors (antigens) influence the survival of grafted tumour cells and 
occur on tumour cells as well as on normal cells (as red cells in this case). 
Following the work of Gorer, initially erythrocytes have been used as test 
cells in histocompatibility antigen (H-antigen) determinations in mice. With the 
appropriate antisera human H-antigens can be demonstrated on all nucleated 
cells, (including reticulocytes (50)), but not or only some of them on erythro-
cytes (80). Leucocytes or lymphocytes from peripheral blood have become the 
most popular cells for testing in larger species than mice, since these cells are just 
as easy to collect as red cells and have a high density of H-antigens on their 
membranes ( 4). 
A practical problem in white cell typing has been found to be the number of 
reagents required. In erythrocyte serology the presence or absence of an antigen 
can usually be determined by the reaction patterns of one antiserum. All antisera 
recognizing the same antigen have essentially the same reactivity pattern. For 
largely unknown reasons this one to one relationship does commonly not prevail 
in serological tests with leucocytes. Here groups of antisera with similar reactivi-
ty patterns are needed to reach a decision on the absence or presence of an 
antigen on the cells of a particular individual. An antigen is only said to be 
present when the majority of the available antisera are positive (the antisera have 
only roughly identical patterns, "false" positive and "false" negative reactions 
often occur). A different nature of leucocyte antibodies or antigens or both 
could be the cause of this complexity. As will be indicated later, the identifica-
tion of the culprit of this complexity has to wait till the results of studies of the 
metabolism and biochemical nature of leucocyte antigens become available (see 
paragraph 6.4.1 ). 
An objective assessment of the presence of an antigen in a particular leucocyte 
suspension can be made with the help of a computer which will sort out the sera 
with common reactivity patterns and allocate the antigen recognized by such a 
group of sera, to those cells, which are positive with a preset number of the sera 
from the group, with the common reactivity pattern. Van Rood (93) initiated 
this approach. His discovery has provided the essential starting point for a host 
of investigations in the last decade on human histocompatibility antigens. 
Mammalian major histocompatibility systems were found to consist of many 
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different alleles, controlling as many antigens. The fact that several antisera are 
needed for the determination of one antigen combined with the fact that many 
different antigens are present, make the population studies of such systems too 
cumbersome for analysis by hand. Again a computerized analysis has made such 
studies possible. 
1.3 CURRENT TOPICS IN HISTOCOMPATIBILITY 
A short historical survey of histocompatibility has been given in 1.2. In part 
1.3 of this introduction chapter, three important current topics in histocompat· 
ibility will be described briefly. 
Identity between donor and recipient for major histocompatibility structures 
favours graft survival, but does not guarantee an indefmite absence of rejection. 
In all the outbred mammalian species investigated, rejection of transplants of 
donors identical for major histocompatibility structures does occur. Non ident-
ity for minor histocompatibility structures will in the long run give rise to 
rejection phenomena in these donor-recipient combinations. However, no de-
tailed knowledge of these systems is available (with the exception of some 
systems in small rodents ( 60, 61 , I 0 I). Therefore the following discussion will 
be limited to major histocompatibility structures. As was pointed out in 1.2 .2 
histocompatibility structures have been investigated by serological methods 
initially. Later cellular methods have been introduced. Previously it was assumed 
that both types of methods recognize the same structures. It will be shown 
(1.3.2) that in several species this conviction is now outdated and contradicted. 
This has led to a change in nomenclature. The major histocompatibility system is 
now called a major histocompatibility complex, since it consists of at least three 
parts: a) and b) two different series of multiple alleles, which control antigens, 
who can be recognized serologically and c) a third system, which is closely 
linked to a and b and controls structures which determine reactivity in cellular 
tests. 
The first topic to be described (1.3.1) i.e. serological testing of major histo-
compatibility antigens and the demonstration of the existence of a major 
histocompatibility complex is directly related to the investigations reported in 
chapters 2-5. It can be read as an introduction to these chapters. The second and 
third topic (1.3.2), cellular testing of histocompatibility and (1.3.3) the biologi-
cal significance of histocompatibility, are the main subjects for future studies 
and have hardly been touched upon in the investigations made for this thesis. 
These topics are nevertheless discussed here to show the relations between the 
three lines of histocompatibility research and to give a more complete survey of 
the field. 
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1.3.1 Serological testing of major histocompatibility antigens. Demonstration of 
the existence of a major histocompatibility complex. 
It will be shown in this section that the existence of one major histocompati-
bility complex has to be proven in studies of families. A priori it would seem 
logical to demonstrate first that a major histocompatibility complex exists and if 
this is proven to be the case, to start the analysis of the constituents of this 
complex in detail. It appears, however, that this approach is only useful in a 
species in which large families are readily available for investigation. In primates 
blood samples of large families are difficult to obtain, since these families are 
scarce (rhesus monkeys and chimpanzees) or the logistics of sampling are compli-
cated (man). In these species the analysis of major histocompatibility structures 
has started "at the other end", i.e. at the population level. First antigens were 
defined in a population of unrelated individuals and then their inheritance was 
studied in families to see if they belonged to the same system or complex ( 8, 9, 
93). In dogs the first mentioned approach (familystudies before population 
studies) is the most efficient one and has therefore been used in the studies to 
be described, since large dog families are common. Moreover the results of 
family studies can be put to good use for the production of more and better 
antisera (see 1.3.1a). An alternative to the demonstration of one major histo~ 
compatibility complex by family studies of antisera patterns is the use of cellular 
tests as mixed lymphocyte cultures between family members (e.g. chapter 6 
reference 24). The question "does a major histocompatibility system exist?" can 
be answered by the taking of five different experimental steps. 
a. production of antisera 
b. typing of families 
c. segregation analysis 
d. transplantation of organs between prospectively typed family members 
e. analysis of major histocompatibility antigens in unrelated individuals 
These different steps will now be discussed in more detail. 
Step a: The production of antisera 
Two different approaches exist for the production of antisera which react 
with histocompatibility structures. 
a. Immunizations carried out between members of different species ("Xeno" or 
hetero immunizations) (31) 
b. Immunizations between individuals of the same species ("allo" or iso immu-
nizations). 
Approach (a) has the advantage that a species can be chosen for antibody 
production, which is practical for economical or other reasons. A drawback of 
"xeno" immunizations is that it is more difficult with this method to obtain 
antisera with a limited reactivity, e.g. versus one antigen only, than when "allo" 
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immunizations are used. It is, however, sometimes possible by elution and/or 
absorption procedures to refine a reagent obtained from xeno immunizations 
sufficiently. An advantage of xeno immunizations is however, that higher titers 
are obtained. (Zweibaum, personal communication). This is of course advanta-
geous, since more individuals can be tested with a limited amount of antiserum 
which can be used in dilutions. High titers are also helpful in immunofluorescen-
ce or other tests, in which serum dilutions have to be used to exclude aspecific 
phenomena. 
"Allo" immunizations have been used more often for the above mentioned 
reason of easier control of specificity of the products. Three approaches are 
available: 
I. pregnancies (88, 92) 
2. immunizations with whole blood, leucocytes of lymphocytes with or without 
Freunds adjuvans (8, !02) 
3. a first set rejection of solid organ allografts. 
The most commonly applied method in human tissue typing is the first one. Van 
Rood et al. and Payne et al. discovered independently that in approximately 
15% of the sera of women, who had given birth to one or more children, 
antibodies against leucocytes of the father were present. The majority of these 
antibodies appeared to be directed against major histocompatibility antigens. 
The great advantage of this method is that no human voluteers are needed for 
the production of human typing reagents (approach 2). Incidentally naturally 
occuring immunization (i.e. pregnancy) does not seem to have an adverse effect 
on the survival of subsequent allografts, in contrast to the fate of allografts in 
multiple transfused patients who have developed antibodies against major histo-
compatibility antigens (13, 53, 85). Many "allo" antisera are made by approach 
2. A situation in between xeno and allo immunizations is found in chimpanzees 
where allo chimp sera have also provided useful reagents for human tissue typing 
(9), as some of the leucocyte antigens of chimpanzees are almost identical to the 
human ones (30). 
In dogs it has been our experience, that a skin graft is a very useful method for 
the production of high quality reagents (see chapter 2). This has also been 
documented for other experimental animals (8). It is important to keep the 
genetic difference between a donor and recipient small. This will limit the 
number of antigen differences between donor and recipient and consequently 
the number of different antibodies produced. Without any knowledge of major 
histocompatibility antigens the situation of limited differences can be achieved 
by grafting between parent and sib. Vander Does et al. (29) have reported on 
studies in which this approach was followed consequently. 
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Method of testing 
The most commonly used test is the microcytotoxicity test in a one (56, and 
appendix) or two stage version ( 1 05). In this test the lymphocyte suspension to 
be tested is added to an antiserum. Complement is present (one stage version) or 
is added later (two stage version) after a period of incubation of cells and serum. 
Cells to which antibody and complement are fixed will be damaged. The damage 
can be visualized, since these damaged cells will take up dyes as trypane blue or 
eosine, while undamaged cells are not stained. 
Other useful methods are the rnicrocomplementfixation test (27) which has the 
advantage of easy antigen storage and rapidity or the fluorochromasia method 
(16). A good viability of cells before testing is a prerequisite. If too many cells, 
aspecifically damaged, take up dye, the effect of an antiserum can no longer be 
evaluated. In the fluorochromasia test, stored lymphocytes with an elevated 
number of dead cells can still be tested. Another advantage is that recently an 
automated test was developed (20). The choice of a particular test will depend 
on the available facilities and the personal preference and experience of the 
investigator. Changes from one test to another can be troublesome, since the 
number of individuals whose cells react with a particular antiserum, depends on 
the sensitivity of the test used. Tests with a higher sensitivity can increase the 
number of individuals positive with a particular serum and thus change the 
previous definition of the factor recognised by that serum. 
Step b: Typing of families 
Family studies can only be done, when the produced antisera indicate 
differences between family members or in other words "segregation" is found. A 
factor present in a parent is said to segregate in the offspring, when some of 
them obtain the factor and others do not. The chance of finding segregation is 
determined by the frequency of positive results of an antiserum in unrelated 
individuals (the so called population frequency of a serum). Sera with a low 
population frequency will often not react with either of the parents. Conse* 
quently no segregation will be found, since the whole offspring will be negative. 
Sera with high population frequencies will be often positive with cells of both 
parents and their whole offspring, so again no segregation of factors is found. 
Twelve sera or more with population frequencies of around 50% give a rea* 
sonable chance of obtaining segregation in every investigated family. These are 
thus minimum requirements for further studies. 
A disadvantage of this approach is that antisera recognizing antigens with high 
population frequencies (as 4a/4b in humans (93)) are initially neglected. 
However in a later stage of the analysis of a histocompatibility complex a 
special search can be made for such antigens. 
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Step c: Segregation analysis 
This analysis is performed on the basis of the following two assumptions. 
I. one major histocompatibility complex (MHC) does exist in the species under 
investigation 
2. the produced reagents contain antibodies against antigens controlled by this 
complex. 
The consequences of these assumptions are illustrated in Tables 1, I a and 1, 1 b. 
Table I. Ia shows the inheritance pattern in a hypothetical family. The paternal 
homologous chromosome pair, carrying the MHC information is labelled A/B. 
Each letter represents one member of this pair or a haploid part of the MHS 
information. Ceppellini (22) introduced the term haplotype for this notation. 
The maternal chromosome pair is indicated by the letters C/D. A maximum of 
four different possibilities exist for the offspring (in the notation used here AC, 
AD, BC and ED). Table 1. I b lists all possible segregation patterns of the same 
family for sera recognizing major histocompatibility antigens. 
With a limited amount of typing sera not all patterns listed in table I. 1 b will 
be found. With the above mentioned assumptions, however, missing patterns can 
often be deducted from those found. For example pattern 3, (the segregation of 
paternal chromosome A or haplotype A) has to be complementary to pattern 4 
(the segregation of chromosome B). If one of the two patterns is missing, the 
missing one can be extrapolated from the one found. Particular families will not 
contribute to the segregation analysis, since by chance all the offspring obtained 
the same haplotypes, or parents are homozygous for the MHC or MHC 
haplotypes are shared by parents. In the typing of some families patterns might 
be found which are conflicting and cannot be explained by the two assumptions 
listed above. 
For example antisera, which are positive for parent one and negative for parent 
two, should have the same segregation patterns or, when they differ, sibs can be 
positive for only one of the two. Sibs, double positive or negative for those 
reagents cannot be explained by the rules laid down in the two assumptions. 
(e.g. child 3 positive for serum 3 or negative for serum 4) 
Sera showing these results should be disregarded for this analysis, but kept, since 
their antibodies might be directed against factors of other systems than the 
major histocompatibility complex. 
One can try to avoid these conflicting results by using antisera from short 
immunization protocols (as a first set skin graft, see chapter 2). Prolonged 
immunization will lead to the emergence of "contaminating" antibodies against 
factors controlled by systems different from the MHC. The occasional occurrence 
of these results is perhaps best explained by serological errors, although crossing 
over as we shall see later (chapter 5) is also a possibility. Another explanation for 
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segregation patterns, conflicting with the two basic assumptions is an agglutina-
tion negative, absorption positive (ANAP) phenomenon (93, 112). In this case 
the presence of a factor can sometimes only be demonstrated by the perfor-
mance of absorption tests. If a serum shows ANAP reactions, some false 
B. 
Table 1.1 
A. Segregation of parental homolog:ous chromosomes carrying 












List of all possible segregation patterns, which can be found for this system with 
serological tests. 
family members SERA 
and 
their haplotypes 2 3 4 5 6 7 8 9 10 
A/B Father + + + + + + + 
c C/D Mother + + + + + + + 
E A c Child 1 + + + + + + 
L A D Child 2 + + + + + + 
L BC Child 3 + + + + + + 
s B D Child 4 + + + + + + 
B D Child 5 + + + + + + 










negatives will be found if only a direct, simple serological test is performed. 
Double negative sibs, as mentioned above could be explained in this way. 
Generally a "best guess" of MHC haplotypes can always be achieved in family 
studies, whenever conflicting segregation patterns are found, since the majority 
of sera can be presumed to give the proper inheritance of MHC haplotypes. The 
frequency of conflicting segregation patterns decreases to zero when optimal 
reagents have been selected after prolonged studies (own unpublished observa~ 
lions). 
Segregation patterns and binomial distribution 
The segregation pattern found can be expressed as a ratio with the more 
frequent chromosome as the first term. In the example of table 1.1 b the ratios 
are B:A = 3:2 for the paternal chromosomes and D:C = 3:2 for the maternal 
chromosomes. It can be shown that the expectations of the possible different 
segregation ratios of a sibship sizeS are the sums of the symmetrical terms of the 
binomial distribution (l/2 + l/2}S when only one homologous chromosome pair 
is involved in the determination of the genetical traits studied (71 ). These 
binomial coefficients can be found directly in a table of a part of the so called 
triangle of Pascal, which is given in table 1.2. Coefficients on one horizontal line, 
belong to the corresponding sibship S. The first and last coefficient of a line are 
always 1. The values of the others can be obtained by adding the two 
Table 1.2 
Part of triangle of Pascal. 
List of coefficients of binomial distribution 
S (sibsize) 
2 2 
3 3 3 
4 4 6 4 
5 5 10 10 5 
6 6 15 20 15 6 1 
7 7 21 35 35 21 7 
etc. 
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coefficients, in the line directly above a particular coefficient. A sibship of 5 
(S = 5) can have the following ratios 5:0, 4:1 and 3:2. These ratios have 
according to Pascal's triangle the following expected relative frequencies 
. _(1+1)_ . _(5+5)_ . _(10+10)_ 5.0- 3l- 0.0625, 4.1- 3'2- 0,3125 and 3.2- 32 -0,6250. 
When a number of families has been typed, the difference between the observed 
and expected segregation ratios can be tested for significance in a statistical test. 
When a non significant deviation from expectations is found the two assump-
tions mentioned in the beginning of this paragraph can be accepted. Thus formal 
proof of the existence of a genetical system or complex on one chromosome pair 
can be obtained. This approach is documented for dog family studies in chapter 
2: This approach cannot be used when selective pressures on the traits under 
study are causing differences in survival of sibs before the time of testing. Such 
an effect could not be demonstrated in human or dog families, typed for the 
major histocompatibility system (71, chapter 2). 
Step d: Transplantation of organs between prospectively typed individuals 
When step 1 , 2, and 3 have successfully been performed, investigations can be 
started to determine the influence of the found genetic region on allograft 
survival. The survival times of grafts exchanged between siblings, which are 
identical for the system under investigation (e.g. children 4 and 5, (table l.lb) 
have to be compared to the survival times of grafts from siblings who are not 
identical (children 2 and 3). If grafts in the former group survive significantly 
longer than grafts in the latter group, one can assume that the genetical region 
involved is a major histocompatibility complex (see chapters 2 and 4 for 
examples of survival times of allografts exchanged between sibling dogs). 
Step e: Analysis of major histocompatibility antigens in unrelated individuals 
Specificity of antisera. 
A sufficient insight into the haplotypes of the MHC in family members can be 
obtained by reagents of limited quality, when the inheritance patterns are clear 
and the family members are only compared to each other. For the determination 
of genotypes in related or phenotypes in unrelated individuals a much more 
detailed knowledge is needed. For this second phase in the recognition of a 
histocompatibility complex many different antisera are needed with low fre-
quencies of positive results in unrelated individuals ("low population frequency" 
sera). They can be obtained by the methods indicated (see I .3.I step a). Sera 
with high population frequencies commonly react against more than one 
specificity (antigen). Such sera are called polyspecific and their results are more 
difficult to analyse than those of monospecific sera. The number of different 
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antigens recognized by a serum can be investigated by absorption experiments 
(see chapter 2, reference 13). In tables 1.3 and 1.4 results are given of 
hypothetical absorption experiments with a monospecific and a polyspecific 
antiserum respectively. All the activity of monospecific antisera is removed by 
absorptions independent from the individual which is used as source for 
absorbing cells, as long as his cells react with the unabsorbed antiserum. 
The activity of polyspecific sera will not be completely removed by all the cells 
used for absorption, since some do not carry all the antigens recognized by the 
sera (table 1.4, cells 2 and 3). 
Absorption experiments are not the final answer towards the question of 
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Table 1.3 














absorbed with cell 





Reactions of unabsorbed and absorbed "poly specific" antiserum. 
SERUM 
unabsorbed absorbed with cell 
2 3 4 5 
+ + + 
c 
E 2 + + + 
L 3 + + + 
L 4 + .+ + 
s 
5 
polyspecificity. Some sera will be monospecific in absorption experiments, but 
recognize nevertheless more than one antigen. This occurs when an antiserum is 
not specific enough to recognize one single antigen. Through its "broader" 
specificity such an antiserum will react with several antigens, which have small 
differences, but also many similarities. This phenomenon has been labelled cross-
reactivity (104). It is a complicating factor in an immunogenetical analysis and 
will be further discussed in 6.4.1. 
Since monospecificity of antisera is difficult to prove, most population studies 
with antisera against histocompatibility antigens are done with crude sera, whose 
poly or monospecificity is not determined. If only those sera are included in a 
population analysis, which have a low population frequency, evidently the 
chances of working with monospecific sera are increased, which reduces the 
complexity of the data analysis. 
Computeranalysis 
It was shown by Van Rood (93), that the reactivity patterns of many antisera 
in large groups of cells of unrelated individuals can be analysed most efficiently 
with the help of a computer. lf this machine is properly instructed it will group 
sera with similar reactivity patterns. The rest of the analysis is based on the 
assumption that sera with similar reactivity patterns recognize one factor (or 
antigen). The genetic and statistical tests which can be applied to investigate the 
relationships between these factors are discussed in the method sections of 
chapters 3 and 5. When enough antisera with low population frequencies have 
been produced and analysed, all or practically all factors belonging to a 
complex will be recognized in a population of unrelated individuals and 
complete or almost complete phenotypes of these individuals can be determined. 
Experiments can then be initiated to test the influence of the complex on 
allograft survival in unrelated donor/recipient pairs. 
Transplantation of organs between prospectively typed unrelated individuals 
In all mammalian species, investigated so far, serological tests have been 
successful in selecting good donors for organ transplantations from a group of 
family members. In humans it has not been possible to document the same 
beneficial effect of donur selection by serological methods in unrelated donor-
recipient pairs. Nevertheless in some studies (28, 57, 94) a favourable effect 
could be demonstrated, it was however not as strong as in related donor/reci-
pient pairs. This discrepancy will be further discussed in 6.6. 1t will be shown 
there that the explanation or a part of it might be found in a better definition of 
histocompatibility structures, recognized by cellular methods. These methods 
will be discussed in the next part of this chapter 1.3 .2. 
27 
1.3.2 Cellular testing of histocompatibility 
Mixed lymphocyte cultures (M.L.C. 's) 
When lymphocytes from two normal, but genetically dissimilar individuals 
from the same mammalian species are mixed and cultured under the right 
experimental conditions for a number of days, a substantial number of the cells 
are stimulated to transform and start to divide. The incorporation of H3 or C14 
labelled thymidine in the newly formed DNA can be used as a quantitative 
measure of this mitotic activity (5, 7). Initially it was thought that the 
thymidine uptake was mainly influenced by differences in serologically defined 
major histocompatibility antigens of the donors of the two lymphocyte 
populations. In general sibs, identical for these antigens did not stimulate each 
others lymphocytes in mixed lymphpcyte cultures. Recently, however, it 
became evident through studies in families or strains in which crossing over 
within the major histocompatibility complex had occurred, that in several 
species, mouse (6), man (32), rhesus monkey (10), and probably dog (see 
chapter 5) M.L.C. reactivity is not governed by the Serological Defined antigens 
(S.D. antigens) but by at least one other genetic system, closely linked to the 
systems recognizing S.D. antigens. This part of the major histocompatibility 
complex has been labelled L.D. (or Lymphocyte Defined). Some investigators 
(26, 47, 95) have claimed a better correlation between serological typing and 
graft survival of unrelated donors when M .L.C. reactivity was also taken into 
account. The question of which part (S.D. or L.D. part) of the M.H.C. is more 
important or whether both play a rOle in graft survival is still unsolved. Van 
Rood (96) has recently proposed .an attractive hypothesis on the basis of data 
obtained in the analysis of human kidney transplantation from unrelated 
(cadaver) donors (53) and from Eijsvogel's et al. (33) in vitro experiments. !n his 
view both parts of the M .H .C. are important. Differences in L.D. structures 
between donor and recipient would trigger (or sensitize) the recipient. The S.D. 
structures of the donor would provide the targets for the immune response of 
the sensitized recipient. This theory awaits further proof and will be further 
discussed in chapter 5 and 6. 
Besides the enormous experif!lental applications of the M.L.C. test, it has to be 
kept in mind that it has the great disadvantage of taking approximately a week 
before an answer is obtained. Therefore, it is unsuitable for a prognostic 
evaluation of histocompatibility when cadaver donors are used. In organ 
transplantations current organ preservation methods routinely allow no more 
than 36·72 hours preservation {14) of an isolated organ. Thus the transplant has 
tG be performed before the results of MLC tests between donor and recipient are 
known. 
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Another limitation of MLC studies used to be that no systematical approach was 
available to study differences in L.D. structures between unrelated individuals. 
An ordinary MLC test between two unrelated individuals does not allow a 
precise identification of the L.D. structures of these individuals. A new approach 
(76), which has been successful in achieving the definition of some L.D. 
genotypes and phenotypes, is mentioned in chapter 5. It consists of the use of 
cells of individuals who are homozygous for their L.D. region of the M.H.C. 
Other new promising approaches are given in a recent paper by Van Leeuwen and 
Van Rood (64). ln the past mixed lymphocyte cultures have been difficult to 
perform in dogs (see chapter 5). Recently a modified technique has given better 
results (Van den Tweel, personal communication). 
The investigations performed for this thesis have mainly dealt with the S.D. part 
of the canine major histocompatibility complex. In 6.6 some, more recent, 
results, which were obtained in collaboration with Van den Tweel and coworkers 
and Grosse Wilde and coworkers on canine L.D. structures will be given. 
Other cellular tests 
In the past three methods besides the MLC test, have been used for a 
"cellular" determination of histocompatibility. These tests are known under the 
names of 
a. normal lymphocyte transfer(NLT)(!8) 
b. third party test (TPT) (70, Ill) 
c. irradiated hamster test (IHT) (91) 
None of these tests is used now very frequently. For technical details the reader 
is advised to consult the appropriate reference. All tests take at least 48 hours, 
cannot directly be interpreted in genetical terms (phenotypes or genotypes), give 
only a rough indication whether a given host-donor combination is good or bad, 
and are only mentioned here for completeness' sake. NLT and TPT have the 
additional disadvantage of requiring the cooperation of human volunteers, who 
will become sensitized to a considerable number of histocompatibility antigens. 
1.3.3 Biological significance of histocompatibility 
The majority of experimental histocompatibility studies have been oriented 
towards the exploration of transplantation immunology. In this part the more 
recent trend to demonstrate a biological function of major histocompatibility 
systems will be illustrated and discussed. Parts of cell membranes, which are 
amenable to analysis because of their antigenic properties, such as histocom-
patibility antigens or blood groups, have astonished scientists by their many 
forms. Individual variation or polymorphism of genetic systems appeared to be 
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greater than was generally expected. The polymorphic features of genetic 
systems, controlling cell surface antigens have in the past been considered as 
clear evidence of a role for all these systems in natural selection ("Pan-selec-
tionism"). 
Pan-selectionism 
Falconer (36) expressed the "pan-selectionism" view as follows: "There can 
be little doubt that the existence of genetic variation is advantageous to the 
evolutionary survival of a species. The advantage it confers being the ability to 
evolve rapidly and so to meet the needs of a changing environment, both 
through the course of time and in the colonisation of new localities ( ). The 
evolutionary significance of genetic variability, however, throws no light on the 
mechanism to maintain it". 
E.B. Ford (39) gave examples of polymorphisms occuring in nature with a 
clearcut role in tbe determination of the "fitness" of an animal. He divided the 
polymorphisms into two groups. 
1. transient, in which a new gene which possesses and preserves an overall 
advantage over its alleles spreads through the population by this selection 
advantage, until the other alleles are reduced to the status of a rare mutant. 
2. balanced, in which the polymorphism that is produced by evolutionary 
changes in a species, comes to a lasting equilibrium after a short period of 
changing gene frequencies. 
Several mechanisms for maintaining polymorphisms of type 2 in balance have 
been documented by Ford (39) and others (110). The one which was most 
regularly assumed to be responsible for doing so, was the so called "over 
dominance" or "heterozygote advantage" mechanism in which the heterozygote 
of a certain system (e.g. A/B) is at an advantage in natural selection, when 
compared to both homozygotes (A/ A and B/B). Two critisisms of the "pan-
selectionism" view have been voiced ( 49). 
1) In several species 30% of the total of genetic information of the species is 
estimated to be polymorphic (48, 67). On theoretical grounds only a limited 
number of these polymorphisms can be balanced and maintained by heterozy· 
gate advantage. If all the polymorphic systems would show heterozygote 
advantage, many homozygotes would be conceived, who are "genetically 
speaking" less fit than the heterozygotes. A difference in fitness can be 
expressed in natural selection in two ways. Less fit individuals die early or 
produce no or decreased numbers of offspring. The observed mortality and 
fertility in primitive human populations where selectional forces are unhindered 
in their expression are not in accordance with expectations based on 30% 
polymorphic genetic systems with heterozygote advantage (21). 
2) Another argument stems from the work of Kimura (55) who, on the basis of 
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a mathematical analysis of the evolution rate of proteins, declares that the 
majority of genetical polymorphisms can be causally explained by random 
changes of gene frequencies. This would add a third type of polymorphism to 
the two classical ones, described by Ford (I) transient and 2) balanced) i.e. 3) 
neutral. Such a polymorphism is also in a transient state, but changes in gene 
frequencies of the alleles of the system are not directed by natural selection, but 
fluctuate through the cause of other genetic mechanisms such as genetic drift, 
migration or mutation (36). Recently reviews of the two opposing theories of 
the significance of polymorphism "pan~selectionism" versus neutrality have 
appeared (21, 49). The interested reader is referred to these articles for details. 
Only a summary of the conclusions reached is given here. The most commonly 
held view now is, that much less genetical variation is significant in terms of 
natural selection, than was formerly thought to be the case. However, well 
investigated human polymorphisms with biological significance have been do· 
cumented (e.g. sickle cell trait, G6PD variations and rhesus blood group system). 
Major histocompatibility complexes have not yet been definitely classified as 
belonging to either the "neutral" (type 3) or the "selection" polymorphisms 
(types I or 2). The available evidence on the possible role of the complex in 
natural selection is discussed below. 
Histocompatibility and natural selection 
A direct search for the influence of natural selection on M.H.C. products is 
impossible since the exact function of these structures is still unknown. This 
makes it necessary to use indirect methods to solve this question of a possible 
biological significance of histocompatibility structures. These methods have been 
divided into three useful categories for blood group polymorphisms by Gersho-
witz and Nee! (42). The same classifications can be used for a description of 
indirect attempts to find evidence for a selection value of major histocompati-
bility antigens i.e. 
1. associations between diseases and certain histocompatibility antigens. 
2. mathematical formulae from population genetics can predict the behaviour of 
alleles and their frequencies in different pppulations under different circum-
stances. Selection, if present, has an effect on gene frequencies different from 
other genetic processes such as genetic drift, mutation and migration. 
3. association between histocompatibility antigens and parameters of biological 
fitness (e.g. longevity, birth weight, reproductive potential etc.). 
Diseases and histocompatibility antigens 
Examples of category I) have been found in two different species man and 
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dog (chapter 4). Human diseases in which a more frequent occurrence of certain 
histocompatibility antigens has been found in patients in comparison to a not 
afflicted control group, include morbus hodgkin (2, 79), glomerulonephritis 
(86), multiple sclerosis (82), lupus erythemathodes (45) coeliac disease (35, 
103), chronic active hepatitis (73), ankylosing spondylitis (19, 98) and myasthe-
nia gravis (90). The strongest correlations between a particular S.D. antigen and 
disease have been found in the last four examples. This could indicate a different 
relationship between disease and antigens in these cases (see paragraph on 
genetic control of disease susceptibility)_ 
In disease association studies two artefacts can occur_ The first one is the 
statistical problem of making many comparisons. This enhances the chance of 
finding improbable events (such as a very uneven distribution of a factor in two 
different populations). When many antigens are investigated in patients and 
normal subjects, some antigens will be abnormally distributed. The observed p 
values of the differences in antigen frequencies in the two populations have to be 
seen in this light and have to be corrected for the number of comparisons made 
( 45). A second artefact is that an association between a particular disease and 
antigen might in fact be caused by a causative relationship between the disease 
and a genetic trait, controlled by a gene very closely linked to the allele 
controlling the S.D. antigen and in linkage disequilibrium with this allele (see 
next paragraph for description of linkage disequilibrium). 
Population genetics and histocompatibility 
Studies in category (2) of Gershowitz and Nee! have been less frequent. The 
best example is the fifth human histocompatibility workshop, in which samples 
of populations from all over the world were studied for major histocompatibility 
antigens and other genetic polymorphisms. For details of the mathematical tests 
and methods used to test whether human major histocompatibility antigens are 
under selective pressure, the reader is referred to the book of Cavalli-Sforza and 
Bodmer "The Genetics of Human Populations" (21). The analysis of the data 
obtained at the workshop, indicated that major histocompatibility antigens are 
indeed significant in terms of natural selection (17). Earlier studies by Bodmer 
and Bodmer (15) and Piazza et al. (89) allowed the same conclusion. 
Another possible example of selectional forces connected to histocompatibility 
is the occurrence in humans of linkage disequilibrium between major histocompati-
bility antigens of different, but closely linked series of multiple alleles (1). 
Generally genes from different systems on the same chromosome are not associat-
ed in a population of random individuals (see Li's illustrating example of the glove 
club in "Human Genetics" (68)). If antigens of different, but linked, series of 
multiple alleles are found more often in the same individual than would be 
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expected by chance alone linkage disequilibrium is said to be present between 
the alleles of the two series. Evidence for linkage disequilibrium between major 
histocompatibility antigens (S.D. antigens) has been obtained in humans (l), 
dogs (chapter 4) and more recently also in rhesus monkeys (12a) and chimpan-
zees (12). One of the possible explanations for this phenomenon is the existence 
of selection pressure favouring special antigen combinations. As mentioned 
earlier a genetic system governing reactivity in mixed lymphocyte cultures, the 
L.D. part of the M.H.C. (see also chapter 5 and 6), is closely linked to the 
systems controlling serologically defined antigens (or S.D. part of the M.H.C.) in 
man~ mice, rhesus monkeys and probably dogs. In populations of humans, rhesus 
monkeys and dogs negative M.L.C. reactions do occur more often in S.D. 
identical unrelated individuals, than in unrelated individuals, differing for these 
antigens (see 6.6). This indicates the existence of linkage disequilibrium between 
S.D. and L.D. parts of the major histocompatibility complex (M.fi.C.) in these 
species. The demonstration of linkage disequilibrium between three closely 
linked loci, the two S.D. loci and the L.D. locus could be interpreted as being 
evidence for a chromosomal region, which is carrying a so called "'supergene". 
R.A. Fischer, who introduced this term, showed (38) that genes, which interact, 
can be kept in close association (notwithstanding the occurrence of crossing 
. over), when only small selectional forces are working on them. Thus the data 
obtained in population genetics do allow the presumption that the L.D. and the 
two S.D. parts of the M.H.C. are kept together by selectional forces and 
therefore that the M.H.C. has a biological function. They do not give an 
indication towards the nature of this biological function. Finally the striking 
similarities between the M.H.C. of different mammalian species (see figure 6.3) 
could be another argument for the biological significance of this complex. 
Perhaps a greater divergence in present day mammals from the M.H.C. model of 
their common evolutionary ancestor would have been found if no selective 
pressures had been connected with this genetic region. 
Histocompatibility antigens and parameters of biological fitness 
Th.is title was given to the third category of the earlier mentioned classifi-
cation of Gerskowitz and Neel, who subdivided investigations into the possible 
biological significance of polymorphic genetic systems. 
In mice (72), guinea pigs (65), rats (46), and rhesus monkeys (11) evidence has 
been obtained for the existence of a genetic control of the immune response. By 
the use of simple antigens for immunizations (e.g. synthetic polymers of a 
limited number of animo acids) genes were found, which controlled the ability 
of an individual to react with antibody formation against the injected antigen. 
The immunological response to each antigen investigated so far is probably 
controlled by a separate genetic system (I 1). Genes belonging to these systems 
33 
have been called Immune response or Ir genes. 
Most of these genes appear to be linked to the major histocompatibility complex 
of a species. Under the heading of Disease and Histocompatibility Antigens, 
several human diseases were enumerated, which showed a positive correlation 
with a certain major histocompatibility antigen. If linkage disequilibrium can be 
proven to exist between h genes and major histocompatibility antigens, a 
reasonable explanation for the increased frequencies of- such antigens among 
patients, with certain diseases can be given. Antibody formation against and thus 
susceptibility towards the causative factor of the disease might be controlled by 
genes of an Ir system. 
The found correlation between diseases and major histocompatibility S.D. 
antigens is then only an artefact (as already discussed in the paragraph on disease 
and histocompatibility antigens), which is created by the linkage disequilibrium 
between lr genes and the particular SD. antigen. Thus the major histocompati-
bility complex might be relevant to important immunological functions of an 
individual if the "supergene" of the major histocompatibility complex might not 
be limited to two genes of the SD. series and one gene of the L.D. series, but 
would also consist of an undetermined number of Immune Response genes. 
Genetic control of disease susceptibility 
Theories about a genetic control of disease susceptibility are manifold. Three 
of them will be discussed here since they can be related to the subject of 
histocompatibility. The first theory has been labelled "mimicry". It assumes that 
a pathological agent is crossreacting with a structure in the patient itself. So if an 
infective or oncogenic agent is very like a "self' component of some individuals 
in a species, those individuals will be more susceptible to these agents, since they 
will not raise an efficient immune response to them. Two· possible examples of 
mimicry have been reported: l) Vogel et al. (108) have demonstrated a cross 
reactivity between Pasteurella pestis and vaccinia with certain ABO blood group 
substances. Their results could not, however, be reproduced by others. 2) Hirata 
et al. and Mittal et al. (52, 78) have found similarities between bacterial products 
and human MHC antigens. A second theory could be named "receptor theory", in 
which a serologically recognized membrane structure is also give a receptor 
function for a pathological agent. Some of the diseases in humans with an almost 
100% relationship between disease and M.H.C. antigens could be examples of 
tltis theory (coeliac disease etc., see earlier paragraph about diseases and 
histocompatibility antigens). At the moment no experimental data are available 
to prove or disprove this concept. The third theory has already been discussed 
partially in the previous paragraph. It links the susceptibility to a disease to the 
capacity of an individual to produce antibodies to the causative agent. Thus Ir 
genes of an individual determine whether he will be able to resist a certain 
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pathogen or not. Experiments performed by Lilly et al. (68a) have shown that 
suceptibility to an experimental induced leukaemia in mice is determined by 
genes from or linked to the major histocompatibility complex of this species. 
This might be an example of the action of Ir genes. Finally two examples will be 
given of diseases in which the circle genetic control of immune response, disease 
susceptibility and histocompatibility has been closed. 
In choriomeningitis in mice (84) and in hay fever in man (66) the immune 
response to an agent, which is not pathogenic on its own, appears to be related 
to the presence of the disease. In both cases linkage between the major 
histocompatibility complex and the genetic control of the immune response to 
the agent has been found. 
Since the first genetic studies of Little and Tyzzer (69) of malignant cell 
transplants several decades of intensive research activities on the genetic control 
of disease suceptibility have passed. Recently it appeared that the major 
histocompatibility complex might be important in this respect. Further histo-
compatibility studies in this direction are evidently of great importance. It has 
provided an additional rationale for the studies to be described in the following 
chapters. 
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SUMMARY 
The production of tissue-typing reagents for dog Jeucocytes by allografting pro-
cedures is described. Skin and small bowel grafts were efficient in producing informative 
sera. A negative correlation was found between the duration of graft survival and the 
subsequent development of cytotoxic antibodies. It was shown that these reagents were 
useful in the selection of littermate donor-recipient pairs for transplantation experiments. 
Evidence presented from family testing and tissue transplantation supports the existence 
of a major (DL-A) histocompatibility locus in dogs. 
The dog is an animal commonly used for trans-
plantation research. Relatively little is known 
about canine histocompatibility (4, 5). In our 
laboratories, the influence of histocompatibility 
testing on allograft survival and the histological 
signs of rejection are being studied. \Vestbroek 
et al. (14) reported the results of canine lympho-
cyte typing on the survival of heterotopic, small 
intestine allografts. The survival periods of 
orthotopic heart allografts in identical and non-
identical beagle littermates were published by 
Bos et al. (3). 
Experiments on the influence of immunosup-
pressive therapy on graft survival in matched 
and mismatched donor-recipient pairs have been 
started in our laboratories. To prove the exist-
ence of organ-specific antigens in the dog is 
another aim of our studies. The purpose of this 
communication is to report how informative 
tissue-typing reagents were obtained and evalu-
ated in studies of beagle families. 
METHODS 
The microcytotoxicity test of Kissmeyer-Niel-
sen, modified by van Rood et al. (12), was used 
to test dog lymphocytes. Skin allografts were 
done following the technique described by Bainer 
(1). Small bowel allografts were done by the 
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technique described by Lillehei (8) and Grenier 
eta!. (6). 
Three immunosuppressive regimes were used. 
(I) Some animals were treated with Imuran. 
Doses were given in milligrams per kilogram of 
body weight, as follows: 6 mg on postoperative 
days 0--5, 3 mg on postoperative days 6-13, 2 
mg on postoperative day 13, and 1 mg/day until 
rejection of the graft occurred. (2) Horse anti-
dog lymphocyte sera (HADLS) were given s.c., 
with 50 mg of Ig/kg of body weight as the unit 
dose. On preoperative day -2, two doses were 
given. In the first 3 postoperative weeks, 3 doses; 
week were given. In the 4th and 5th postopera-
tive weeks, 2 dosesjweek were administered, and 
in the 6th postoperative week, 1 dose. (3) 
Another group of dogs was treated with Imuran 
and HADLS, following the schedules described 
aboye. 
The sera of dogs that rejected skin or small 
intestine allografts were harvested 8-10 days 
after rejection and were tested for the presence 
of allolymphocytotoxins against the cells of 40 
random beagles. All animals were boosted by the 
s.c. injection of whole blood at five different sites. 
A serum sample was taken 5-8 days after boost-
ing. In selected cases, boosting was r-epeated at 1 
month. 
Beagles were obtained from the Centraal 
Proefdierenbedrijf T.N.O. (Zeist, The Nether-
lands; Dr. J. van Vliet) and our own colony. The 
family studies ''·ere done in those colonies. 
RESULTS 
Production of typing sera. Forty-four sera 
harvested after rejection of skin or small bowel 
homografts were tested against the lymphocytes 
of a standard panel of 40 random beagles with 
the microcytotoxicity test (Table I). Sera were 
considered pattern I if they gave negative or 
doubtful positive results with the cells of the 
test dogs. Sera were pattern 3 if they gave posi-
tive results with more than 75o/o of the dogs 
tested. Sera with pattern 2 were the so called 
"informative group1' with positive results in 
less than 7 5% of the dogs. 
Boosting 10 dogs \vith serum of pattern 1 did 
not yield "informative sera." Their sera remained 
of pattern I or developed a pattern 3. It took 6 
months or more before 7 dogs \Vith sera pattern 
3 developed a lower frequency of positive results 
with the 40 cell samples. 
Informative sera from dogs remained useful 
1vhen harvested in the first 2Y2 months after re-
jection, ,~.rithout boosting. Boosting at that time 
or later produced, in 2 of 10 dogs tested, sera 
\Vith a higher frequency of positive resttlts with 
the cells of the standard group. 
Skin grafts (nonvascularized) were compared 
to small bowel grafts (vascularized) for their 
efficacy in producing useful typing sera (Table 
1). Skin grafting seemed to be a better method 
of producing typing sera, although this difference 
in efficacy \Vas not statistically significant. 
By comparing long, intermediate, and short 
survivals in skin and small bm.vel allografts (Ta-
ble 2), a statistically significant (P < 0.001) 
correlation between serum patterns and survival 
periods (r, 0.64) \vas ob:;;;erved (7). Survivors 
that maintained the grafts for prolonged periods 
did not produce antibodies in most cases (pat-
tern 1), \Vhile short graft survival was most com-
monly associated with antibody production of 
patterns 2 and 3. 
Animals receiving allografts from more than 
one donor and animals 11sed to test HADLS in 
Yivo in skin allografts are not included in Table 
~-
Studies of cytotoxicity rrsults in beagle fami-
lies. Twenty sera with an informative pattern, 
TABLE 1. Serum patterns 8-10 days after rejection 
of different allografts 
Sera with pattern 
Allograft 
Total 
Small intestine 10 5 3 18 
Skin from one donor 5 9 2 16 
Skin from two donors or 0 4 6 10 
more 
Total 15 18 11 44 
obtained in Rotterdam, and 38 sera raised by 
Cleton (4) were used to tissue type beagle 
families. At the time of the study/ no "operation-
ally// monospecific antisera ( 13) recognizing de-
fined dog leucocyte antigens were known. 
IYiost of our antisera gave positive results with 
more than 50% of the beagle colony. N everthe-
lcss, \VC were able to divide littermate beagle 
pairs into thrre different histocompatibility 
groups, if \Ve assumed the existence of one major 
dog histocompatibility locus (DL-A) and that 
our sera recognized mixtures of antigens of this 
locus. 
Table 3 shows an example of the haplotyping 
of a family by a panel of 58 sera. Although the 
TABU~ 2. Survival periods of allografts compared 
with serum patterns after rejection" 
Survival period 0 
(Pattern): 1 Total Score 
(Score): 3 sera 
Short 3 1 6 4 11 
Intermediate 2 2 2 4 
Long 1 10 4 14 
Total 13 12 4 29 
" Correlation of graft survival to serum pat-
terns significant at P < 0.001. 
b Short. survival-skin grafts and small intes-
tine grafts rejected within 10 days after transplan-
tation; small intestine grafts rejected within 20 
days after transplantation ·when treated with 
antilymphocyte serum (ALS), Imuran, or both. 
Intermediate survival-skin grafts rejected be-
tween 11 and 16 days; small intestine grafts re-
jected behveen 10 and 20 days; small intestine 
grafts treated with ALS, Imuran, or bot.h, rejected 
bet\veen 20 and 40 days. Long survival-skin 
grafts rejected in 16-21 days; small intestine grafts 
rejected after day 20; small intestine grafts 
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litter 16 17 23 43 
---
--· 
---- -- --·--- ·--- --- ----- ---- -- --- -·--- -- --- --------
---· 
Father ++ ++ ++ +' ++' ++ - - - - -
Mother - (+) - - ++++ +++' ++' ++' + 
Litt.ermates 
I 0' +++ ++' ++ ++ +++ +++ A ++' +++ +++' ++' ++ 
20' ++' ++ +' + +++ ++' A +' ++' +++' ++' ++' 
30' +++ ++' +' ++' +++ ++' A ++' ++ +++ +++ ++ 
40' - - + +' B ++' ++++ ++' +++' + 
5 9 ++ - ++ - - -- B - - - - -
6 9 +++ ++ ++ +' ++++ +++ A - - - - -
7 9 +++ ++' ++' ++ +++ +++ A (t) - - - -
8 9 ++' ++' +' +' +++ ++ A ++ (t) +' ++ (+) 
Haplotypes A A A A A A D n D D f) 
recogni:?;ed 
-~-·"------
a Only those panel sera are shown which gave clear positive and negative results among the litter. 
1> Positive reactions with father; negative with mother. 
c Negative reactions with father; positive with mother. 
d Positive reactions wit-h both parents. 
+++ +++' +++ ++' 
++ ++' ++ ++' 
D All - +++ +++ 
D AD - +++ +++ 
D AD - +++ +++ -
]) BD ++' ++ - -
c BC +++ - ++' +++' 
c AC +++ +++ ++' ++' 
c AC ++ +++' ++' +' 
D All - +++ ++ -
BC All AC C/BC 
? 
-·---- ------·-
actual antigens of the DL-A haplotypes of the 
parents were not clearly recognized, \Ve were able 
to locate the parental haplotypes A and B for 
the father and C and D for the mother, in the 
litter. In the group of sera that reacted posi-
tively with the father's lymphocytes and nega-
tively with the mother':::;, two different types 
of sera could he present-one type following 
haplotype A and one following haplotype B in 
the litter. The groups of sera negative with the 
father's lymphocytes and positive with the 
mother's can show also tvvo different patterns 
of results in the litter, one indicating haplotype 
C and one, D, In the family shown (Table 3), 
only haplotypes A and D are recognized. In 
other families, we sometimes found sera for all 
four haplotypes. 
Jn the depicted family, siblings 1, 2, 3, and 8 
are examples of DL-A-identical littermates, 3 
and 4 differ in one DL-A haplotype, aw:l· 5 and 
S have two DL-A haplotype differences. \Vith 
the described panel of test sera, we were able 
to recognize 58% of the DL-A haplotypes in 50 
beagle families. \~lith a new panel, from which 
\Ve removed 18 sera of the first panel and to 
which we added 19 more recently produced in-
formative sera, we succeeded in recognizing 75% 
of the DL-A haplotypes in 40 beagle families 
from the same parents. 
Evidence for the existence of DL-A. Table 4 
shows the segregation analysis of parental chro-
mosomes as described by .:\dattiuz et al. (9). We 
studied only the beagle families in which the 
paternal and/or maternal haplotyprs showed a 
clear-cut segregation in the litter. 
In the family shown in Table 3) the paternal 
segregation ratio is 6:2 (A:B), the maternal 
segregation ratio, 5:3 (D:C). The low x~ values 
shmv an excellent fit with the hypothesis that 
our antisera recognize an antigenic sy~tem \vhich 
segregates in the F1 , following the law::; of :\..Jendel 
for a hereditary trait. governed by one chromo-
somal locus. Figure 1 sho•vs the graft survival of 
different. organs exchanged between beagle litter-
mates. Each bar is the medium graft survival 
t.ime of six allografts or more. The survival pe-
riods correlate very well with the haplotype dif-
ferences behveen donor and recipient. 
These results indicate that the antigenic sys-
tem recognized by our antisera. is governed by 
one chromosomal locus \vhich has ovE'rriding im-
portance for allograft sun·ival. In analogy to the 
HL-A system for human leucocytes, thi" locus 
ha; been called DL-A, 
DISCUSSION 
Our results clearly show that the production 
of typing sera is rather easy in transplantation 
laboratories. Postpartum sera were. in our ex-
perience, less successful. Only one informative 
serum was obtained out of eight bitches tested. 
The i.v. or s.c. injections of cdls to rai:oe dog 
alloantisera have the disadvantage that long im-
munization schedules are necessary. It is re-
ported in the literature that after long immuni-
zation schedules antibodi0s lose their Epecificity 
TABL~; 4. Patemal and maternal DL-A chromosomes segregating in litters of different sizes" 
Segre· Ko. of Ko. of litters segregatin;; I .:-Jo. of Ko. of litters segregating 
gation litters I litters Litter ratio of with X~ with ,, size (s) haplo· paternal Expected Observed maternal Expected Observed 
types 0 segre- segre-gation gation 
4 3: I 8 4.57 5 0.09 8 4.57 5 0.09 
2:2 3.43 3 (I DF) 3.43 3 (I IJF) 
5 4:1 13 4,33 5 0,15 12 4 2 1.50 
3:2 8.67 8 (1 DF) 8 10 (I DF) 
G 5:1 22 4.25 4 0.79 2:l 4.45 7 1.89 
4:2 10.65 9 (2 llF) 11.13 9 (2 DF) 
3:3 7.10 9 7.42 7 
7 6:1 18 2 0 2.27 17 1.89 2 0.13 
5:2 (j 7 (2 DF) 5.67 5 (2 ll F) 
4:3 10 II 9.33 10 
" Analysis as described by lvlatt.iuz et al. (9)' 
11 The chances of the different segregation patterns follo'v the coefficients of the formula (1.-z + 1.2)"'. 
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FIGuRE 1. Mean sunival times of different allografts m identical and nonidentical 
beagle littermates (without immunosuppressive therapy). 
and gain avidity. Therefore, we ronsider alia-
grafting of solid organs the best \Vay to produce 
dog alloantisera (2). 
It is possible that, ini5tead of s.c. injections, a 
serond allograft from the same donor would be 
a better way of boosting. Thi~ possibility will be 
investigated in further experiments. Until more 
i~ known about the major dog histocompatibility 
locus, the described methods and the produced 
sera will enable us to tissue type littermate 
beagles with sufficient accuracy to be able to 
select identical and nonidentical littermates. 
The existence of a major dog histocompati-
bility locus is very probable, as shown by the 
results of our studies, and is in accordance with 
the results reported by Epstein et al. (5) and 
Rapaport eta!. (10). 
We follow several approaches in trying to de-
fine dog leurocyt.e antigen:-:. First, antisera with 
common reactivity are identified. For this the 
computer ha::; been helpful (11). Second, ab-
sorption and elution studies arr done for refine-
ment of ttntigenic recognition of thC' nntit>era. 
Final!~·, planned transplantation.:~ with knmvn 
DL-A antigPn diffrrencf'::::. are done. \Ve expect to 
be able to report in the ne.1r future on DL-A 
antigens found by these approaches. The knowl-
edge of defined DL-A antigens will also farilitate 
the trping of random dogs. 
It. is possible that dog leucocyte antigens are 
different in v:nious part!'! of the world and in 
ntrious breeds, because of selerti\·e breeding 
and/or genetic drift. Therefore. it would be most 
profitable to exrhange typing reagents between 
dog laboratories. 
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POLYMORPHISM OF THE DL-A SYSTEM 
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Laboratory for Experimental Surgery, Medical Faculty, Rotterdam, and Department of 
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SUMMARY 
The major histocompatibility system of the dog (DL-A) was studied in more detail 
by immunogenetical methods. Suggestive evidence for the existence of two closely linked 
DL-A (sub)loci was found. The definition of three alleles at the first sublocus was clear 
for both mongrel and beagle populations. Three additional specificities appear to recog-
nize antige.ns of a second sublocus, at least in the beagle colony. Differences in the 
frequency of the described specificities were shown between the mongrel and the beagle 
populations. 
The .e:xi.stence of a major histocompatibility 
system, located on one or several linked loci of 
one chromosome pair is well established in man 
(HL-A) (1), mouse (H-2) (16), rat (Ag-B) 
(11), rhesus monkey (RhL-A) (4), chicken (B) 
(.9), and pig (PL-A) (22). A similar genetic 
system in dogs (DL-A) has been anticipated 
( 12). Evidence for the existence of this system 
has been obtained by serological and graft sur-
vival studies (5, 23, 26) and by mixed lympho-
cyte culture experiments (18). 
The purpose of this article is to describe the 
experiments performed to investigate the DL-A 
:::;ystem in more detail. 
Immunogenetical methods were applied to the 
results of cytotoxicity tests performed on the 
cells of 100 random mongrel dogs and 77 ran-
dom beagles with 26 selected canine alloantisera. 
The same dog alloantisera were used to type the 
cells of 70 beagle and 10 mongrel families. An 
attempt was made to explain the obtained re-
sults by the assumption of the existence of one 
series or more of multiple codominant alleles in 
the chromosomal DL-A region. 
MATERIAL AND METHODS 
Dogs 
?\1ongrel dogs and their families were obtained 
from local dog handlers and breeders. Beagle 
families were studied in a colony of Het Cen-
tr:tal Proefdierenbedrijf TNO, Austerlitz, Hoi-
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land (Dr. J. van Vliet) and in our O\Vn colony 
(Dr. W. van Dijk). 
The group of random beagles was composed 
of animals which came from six different beagle 
breeders. Beagles which were bought from one 
breeder were considered random when pedigrees 
were available sho\ving that the animals were 
unrelated or that they were born on different 
days. However, the possibility that some of the 
beagles included in the random group had a 
common ancestor could not be completely ex-
cluded. 
Alloantisera 
The production and evaluation of dog alloan-
t.isera have been described previously (23, 24). 
Briefly, dog alloantisera were obta.ined after 
multiple injections of leucocyte suspensions, 
after pregnancies, or after the rejection of trans-
planted solid organs. Our method of choice at 
the moment is a skin allograft exchanged be-
tween dog littermates that share one parental 
chromosome, carrying the genetic information 
for DL-A (one DL-A haplotype difference). 
Antisera were screened for antibody activity 
·against the cells of at least 40 random beagles or 
mongrel dogs. Twenty-six antisera. from 26 dif-
ferent dogs ( 4 mongrels and 22 beagles) had 
promising screening results (clear positive reac-
tions with a population frequency of 0.50 or 
less) and were used as the panel of test sera. 
The random mongrel dogs and beagles were 
tested against this panel in duplicate on 2 differ-
ent days. The beagle families were tested once, 
while the mongrel families were tested on at 
least two different occasions. 
Cytotoxicity Test 
The microcytotoxicity test as described by 
Kissmeyer-Nielsen and modified by van Rood et 
al. (21) was used. In these studies this test had 
a reproducibility of more than 85%. 
Immunogenetical Methods 
Population studies. The reactivity patterns of 
the antisera in the two dog populations were 
analyzed with the help of computer .programs 
(13). Sera >vith common reactivity patterns 
were analyzed as a group (cluster). 
In general, only those typing results were used 
for further analysis that sho>ved a concordant 
negative or positive cytotoxicity test on two dif-
ferent occasions. Discordant results were re-
garded as "not done)) and >vere always left out 
from the analysis except in the data in Tables 3 
and 4 when these results were scored as negative. 
Results of the cytotoxicity tests of the lym-
phocytes of the random dogs were compared in 
2 X 2 contingency tests. Two different X2 tests, 
described extensively by Andresen et al. (2), 
·were used. The first x~ test has been called x~ 
test for independence, because it assumes that 
the reactivity patterns of the two antisera in 
question are independent. In this test a x~ value 
>3.8 shows (P < 0.05) a positive association be-
tween the two antisera when ad > be or a nega-
tive association \Vhen be > ad (a, b, c, and d 
being, respecti,·ely, the+ +,- +, + -,and-
- results in the 2 X 2 table). 
The second x~ test has been named X2 test for 
allelism. It a.'3sumes that the two antisera in 
question detect t\vo specificities that are con-
trolled by t.\YO different alleles of one genetic 
system which are in Hardy-VVeinberg equilib-
rmm in the population in study. 
A X2 value >3.8 in this test is not compatible 
>vith an nllelic relationship of the two specifici-
ties in question. The rationale of using two dif-
ferent X2 tests is that the X2 values of either test 
often do not reach statistically significant levels 
in a small sample, especially when the gene fre-
quencies of the studied specificities are low. In 
such a case the most probable relationship be-
tween the two specificities can nevertheless be 
found, if the two different X2 tests support the 
same of the two alternatives (allelism or inde-
pendence). 
If, by applying these tests, evidence is found 
for the existence of a system of multiple alleles, 
no subject in the population should possess more 
than two specifiCities of one series of multiple 
alleles (absence of "triplets"). Gene frequencies 
of the studied specificities were determined by 
using the formula, GF = 1 -VI - j, where f 
is the population frequency of the specificity in 
question. 
Family studies. Population statistics and seg-
regation analysis can support and supplement 
each other ( 6, 8). The segregation patterns of 
the cytotoxicity results of the panel sera with 
the cells of dog families '\Vere used to allocate 
DL-A haplotypes to the individual family mem-
bers (23). 
T'\vo antisera or two clusters of antisera that 
seemed to have an allelic relationship in terms of 
population statistics were checked in double 
backcross matings (1/2 X -/-, 1 and 2 being 
the allelic specificities of the genetic system). No 
littermates 'vith both or neither of the specifici-
ties should be present. No DL-A haplotypes 
"With two components of one series of alleles 
should occur (absence of "doublets"). Independ-
ent specificities can be present in the same litter-
mates from another type of double backcross 
mating (1,4/-,- X -,-/-,-), 1 and 4 
being two specificities belonging to two different 
series of multiple alleles. The same type of dou-
ble backcross mating can be used to find support 
for the concept that t\VO independent series of 
multiple alleles are located on the same homolo-
gous chromosome pair. 
These data were not eAi.ensive enough for 
analysis using standard tests for the estimation 
of linkage (6). 
The number of negatiYe animals in dog fami-
lies of mating type+/- X-/- (a single back-
cross) "ere used to determine whether the segre-
gation beha,·iour of the studied spec~ficities was 
compatible with the segregation pattern of a 
dominant ~Iendelian character (14). 
:NOMENCLATURE 
In the future, agreement will have to be made 
on a standard nomenrlature for the antigenic 
determinants of the DL-A system. In this paper 
the antigenic determinants hnye been assigned 
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arabic numerals, preceded by the initials DL to 
emphasize that they have been defined on dog 
lymphocytes. DL 1 is detected by sera 3897 and 
3895; DL 2 is detected by serum 7883; DL 3 is 
detected by serum 7884; DL 4 is detected by 
sera 7865, 7875, and 7882; DL 5 is detected by 
sera 7878, 7833, and 78i7; DL 6 is detected by 
serum 7864. Serum 7833 (DL 5) and serum 7864 
(DL 6) were obtained from mongrel dogs. The 
others were from beagles. 
As of yet, absorption experiments (24) have 
only been performed with serum 3897 (DL 1) 
and 7865 (DL 4). Leucocytes (10") were used 
per 0.1 ml of serum. Absorptions were carried 
out ·with suspensions from 10 unrelated dogs re-
acting positively \vith the unabsorbed antiserum. 
The results indicated that these antisera are 
probably operationally monospecific. 
RESuLTS 
Figures 1 and 2 show the i values of inde-
pendence for 16 antisera arranged in a triangle. 
Sera were clustered within one specificity if their 
X2S for independence were significantly high. 
Sera. such as 7882 and 7877 were included in the 
DL 4 and DL 5 clusters, respectively (Fig. 5), 
even though they ,,·ere dearly broader than the 
main specificity. In the event of equivocal re-
sults within a cluster, the results of a leading 
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S<'ra from the panel are not depicted. These sera 
either gave inconsistent results in the family 
f:tudies (for example, the cells of the dame and 
Bire were negatin and the cells of some of the 
litter \Ve-re positive).· or included one or more of 
the specificities in the triangle. A comparison 
between the results in mongrels and beagles 
i:!hows that, in general, the same statistical rela-
tionship exists bebveen the different anti:Sera in 
the two dog populations. There are, however, a 
number of exceptions. The most notable differ-
rnce is the negatiYe association behveen DL 5 
(sera 7878, 7833, otnd 7877) and DL 6 (serum 
7864) in beagles, ·which have a high positiYe 
a~sociation in the mongrel population. 
x~ Tests for allelism (Figs. 3 and 4) indicate 
that some sera could have allelic relationships. 
The possible relation::;hips between the antisera 
become dearer when the results from Figures 1 
and :2 and 3 and 4 are compared (Table 1). 
T\ro ;'allelic" antisera have a negatiYe associa-
tion \Vhen tested for independence and a 10\V X2 
value for allelism. Two "independent'' antisera 
will h:n·e a low x~ Yalue for independence and a 
high x~ value for nllelism. In Table 1, on!~' one 
~rrum/qwcificity is shmvn. DL 1, DL 2, and DL 
:3 seem ro be the <tntigenic determinant.~ of a 
fin•t serit's of multiple :tlleles. The data suggest 
that. DL 4, DL 5, and DL 6 are independent of 
this first series. The re~pectiYe x" Yalue.s for in-
[7864 5. 8 ~ §_J_ l..:.l !:.2. ~ 5 . 4 ~ .!1...:2 17.3 
[3896 2.6 1.3 .Q...:..§_ 37.9 2. 5 1.1 L6 I • 6 0.0 1.0 
7845 0. 8 u 1..:.§. 1 7. 7 9:5 6. 8 9:6 3.2 I . S 2.7 
[3894 0.4 0. 5 3.6 4. 2 16.6 13.5 12.7 I . 7 5 . 9 0 . 5 22.4 10. 1 1.1 
7866 0.8 0":2 L:.Q 10.9 2.8 3.9 2.5 2..:3. 0. 8 2.3 25.9 14:8 5. 5 
[7824 
.l.2..:.l. 21..:.1 o.o I. 0 l..:..§. ~ 2.6 0. I 2..:1. Q...:2 z. 7 Q.:...!. Q.;__§_ 7.2 0. 1: 
3 3 7 7 7 7 7 7 7 3 7 3 7 
8 8 8 8 8 8 8 8 8 6 8 8 8 8 8 
9 9 8 8 6 7 8 7 3 7 6 9 4 9 6 
7 5 3 ~ ~ 5 5 z 8 3 7 ~ 6 5 4 6 
DL1 D LZ Dl..3 [. L4 J l5 D L6 U~<ASS I Gf.:ED 
FIGURE 1. x2 Values for independence (1 DF) between serum pairs tested in 77 beagles. 






[7884 I . 5 2. 6 0. 6 : 
[7865 I. 6 0.2 1.6 0. 5 7875 -1.-1 0.4 I. 3 3.3 
7882 0:0 0:4 0.7 2.4 
[7878 5. 3 8. 0 3. I 3. 9 0.6 0.7 0. 2 7833 4. 5 9. I 4. I "3.""4 0":"1 0:0 077 
7877 7.3 6. 5 1.0 I. 2 0.2 Q.:..l 0. 3 
[7864 1.6 0.2 ~ 2. I 1..:..2 2..:1. 1.5 13.2 10. 1 15.6 
[3896 3. 9 0. I 0. I 2. 6 0. 1 0. I 0. 3 2. 8 4.2 0.3 
7 84 5 3. 2 T:3 2. I I. 6 o.o 0.4 
..C2..:.2 6.3 3. 2 0.3 
[3894 0. 8 1.1 0. 3 2.0 6.7 5. 9 8. 4 1.6 0. 9 0.0 0. I 0.2 4. 0 
7866 1 2. 6 6.9 4.3 0.2 I . 4 0. I 0:0 9. 3 4.7 5. 6 4":1 0. 9 2. 3 
[7824 I. 2 2..2 0.0 3. 2 o.o 0.4 0. 0 I .3 0. 0 2..:.2 0. 6 5.3 4. 0 6.8 6.6 
3 7 7 7 7 7 7 7 7 7 3 7 3 7 
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 
9 9 8 8 6 7 8 7 3 7 6 9 4 9 6 
7 5 2.., ~ 5 5 2 8 3 7 ~ 6 5 6 6 
C' ll Dl2 Dl3 0 l4 D l5 Dl6 UNASS 1 GNED 
FIGLRE 2. x~ Values for independence (1 DF) between serum pairs tested in 100 mongrel 




3895 1.32·;]; ... 
[7883 
················· 
1.6 3.6 ...... 
[7884 0.3 0. I 1.0 .. 
[7865 1.7 4.6 2.9 0. 2 7 8 7 5 1.6 4.4 1.2 0. I {i;.:6: 
7882 4.5 8.3 3.3 0. 4 PT.:9; ~:Q:q;;';! 
r878 2.0 5.7 88.9 1.4 0. 3 0. 0 1.4 
······· ..... 
7833 5.7 6.7 85.9 0.0 0.5 0. I 1.3 :13:;:1: 
7877 3.6 4.0 44.4 1.5 9. 0 6. 6 9. 4 :67::2 :1.3:;:a 
[7864 0. g 0.3 1.1 1.5 0. 2 0. 3 0. 0 2.4 3.6 4.5 
········ 
[3896 1.2 0. I o.o 71.9 0.0 0. 7 0.4 9.7 2. 9 8.5 
7845 0. 3 0.0 7. 5 50.3 0.6 0. 0 0. 3 13.7 9.8 15.7 
[3894 0.7 0. 9 12.7 0. 2 2.6 1.4 I. I 12". 1 18.8 4.0 73. 1 0. 5 6. 7 
7866 4.4 3.0 8. 2 0. g 0. 4 0.2 0.8 1.6 4.8 0.4 77.7 2.5 0. 3 
[7824 3.9 3.9 3.3 1 6. 4 2.1 0. 8 6. 4 4. 9 4. 0 10.4 2.6 9. 8 168.3 31.0 2.3 
3 3 7 7 7 7 7 7 7 7 7 3 7 3 7 
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 
9 9 8 8 6 7 8 7 3 7 6 9 4 9 6 
7 5 3 ~ 5 5 2 8 3 7 ' 6 5 9 6 L.J L.J '--------' 
D L 1 OL2 DL3 DL4 oL5 D L6 UNASSIGNED 
FIGURE 3. x~ Value,; for allelism (1 DF) between SE'rum pairs trstE'd in 77 beagl('s. 
dependence and allelism indicate that DL 4, DL 
5, and DL 6 could be the antigenic determinants 
of a second series of multiple alleles in beagles 
but not in mongrel dogs. 
Table 2 shows the gene frequencies for the six 
specificities in mongrels and beagles and the dif-
ferences between the two populations. These 
gene frequencies were used to calculate the gene 
frequency of a postulated blank all8le(s). They 
were used to calculate the expected number of 
different phenotypes per serieS. The gene fre-
quencies (Table 2) and the family studies (Fig. 
5) for the nonassigned antisera are not given 
here because their analysis is still in a prelimi-
nary st<tte. 





[7883 0.4 1.1 
[7884 0. I 0. I ["" 0. 0 0. 5 7875 0. I 0.3 7882 4. I 4. 9 ["" 28.6 24.0 9. 7 0 ;1 0. 6 0.5 2.3 7833 19.2 25-6 11.7 0. 0 3. 9 2. 8 8. 5 7877 33.4 21 .1 5. 0 1.6 6.0 3.4 9. 5 
[7864 1 1. 3 5. I 0. 0 10.6 1.1 1.7 0.2 37.8 33.0 
[3896 16.8 I . 5 1.5 12.1 4.0 4.6 7 .o 16.7 1 9. 5 1 5. 2 
7845 17. 1 8. 5 8. 2 12.3 4. 0 6. 5 1.7 29.4 20.9 27.3 
[3894 7.5 0.0 2.7 o.o 2.0 1.2 2. 8 11.3 9. 0 7.4 2.7 6. 0 14.8 
7866 32.0 20.8 4. 3 1.5 0.0 1.4 2.9 30.2 1 9. 0 26.6 4. I 9. 0 14. 1 
[7824 9. 3 1.5 1.2 13.2 2. 5 5. 1 2. I 1.2 4.9 0.3 1. 7 20.9 20,4 22. 1 20.4 
3 3 7 7 7 7 7 7 7 7 7 7 3 7 
8 8 8 8 8 8 8 8 8 8 8 8 s 8 8 
9 9 8 8 6 7 8 7 3 7 6 9 4 9 6 
7 5 12.! CJ 5 5 2 8 3 7 4 LJ 6 5 c~ 
OL 1 OL2 QL3 OL4 DL5 016 UNASSIGNED 
FIGURE 4. x~ Values for allelism (1 DF) between serum pairs tested in 100 mongrel dogs. 
J~lrts were found and that the observed numbers 
of different phenotypes in mongrels and beagles 
agree very well with the null hypothesis of a.t 
least 4 allelic specificities. In the second series 
(Table 4), one mongrel was positive for DL 4, 
DL 5, and DL 6. In beagles no triplets were 
found. However, in both mongrels and beagles. a 
sufficiently good fit of expected and observed 
results could not be obtained to statistically con-
firm a second series. 
TABLE 1. x2 Values of independence and allelism 
between serum pairs 
Sera and specificities 
3897(DL l)-7883(DL 2) 
3897(DL I)-7884(DL 3) 
7883(DL 2)-7884(01 3) 
7875(01 4)-3897(DL 1) 
7875(DL 4)-7883(DL 2) 
7875(DL 4)-7884(DL 3) 
7878(01 5)-3897(01 1) 
7878(DL 5)-7883 (01 2) 
7878(DL 5)-7884(01 3) 
7864(DL 6)-3897(01 1) 
7864(DL 6)-7883{DL 2) 
7864(01 6)-7884(DL 3) 
7875(DL 4)-7878(DL 5) 
7875(DL 4)-7864{DL 6) 











8. 0 47.1 
3. 4 0.2 
1.6 5.8 
0. 2 6.1 
2.1 1.2 






































a Italic ::~;:2 values indicate H negative association. 
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TABLE 2. Gene frequencies in two dog 
populations 
Gene frequency (SE) 1
1 Antisera I Specificity . detecting ------,------


















0. 0541 (0 .0187) 0.1088 (0 .0270) 
0.1528 (0. 0296) 0. 2ll8 (0. 0355) 
o .1044 co. o225 J lo. 2478 co .0404) 
0.3195(0.0337) 0.1571 (0.0295) 
0.2478(0.0404) 0.3134(0.0469) 
In Figure 5 ::;everal examples of segregation in 
beagle (families 1-5) and mongrel (families 6-7) 
families are sho·wn. DL-A haplotypes could be 
allocnted using the panel of 26 sera in 61 out of 
the 70 beagle families and 8 out of the 10 mon-
grel families. An easy way to haplotype a dog 
fnmil~- is to study the serum reactions ·which are 
positin' -..vith the cell:s of the sire and negative 
with the cells of the dame (a paternal back-
eros~). These sera can have two different pat-
terns in a litter. one recognizing the segregation 
of haplotype A, and the other recognizing the 
segregation of haplotype B (for example DL 1 
nnd DL 4 in family 2). In a similar -.,vay, one 
Anti sera Antisera 
first series second series 
3 3 7 7 7 7 7 7 7 
8 8 s 8 8 6 8 8 8 
9 9 8 8 7 8 7 3 7 
5 7 3 4 5 5 2 8 3 7 
' 5TI [1[2 DL3 DL4 DL5 Die; 
I 53 1 '6/-. ~ -~ 3 • • -I• • • • • • 1 65 -,4/-,6 CD • • • - • • 607 AD • • 
_, 
• 
608 AC • • • • • - • • 
590 AD • • • • 
59 I sc • • • • • 
F i 5.3 I , 6/-, 4 A8 • • • • • • • 
:-1 s. 2a 2' 5/.3.- co • • • • • J 0 . .347 AD • • • • • 
J 0.348 PC • • 8 • • • 8 J 0. 349 i:C • • • • • • 
J 0 . .350 sc • • • • • 
J 0. 3 51 sc • • • • • • • 
0 0 . .352 erJ • • • • 
0. 3 I 3 8(; • • • • - • 
0. 315 Al' • • • • - • 
\·,~rr i ~r 3, ~I-, 4 
'" I 5' 
" 




9. 171 'C 
"' 
s~ 
: 7" ~) 
0. I<~ ''C 
0. I< 5 ')J • 
';37 -,en ,5 




·J. 291 GC• 
0. 292 
2"·" •s 
•.20:.7 ., •0 
2<0 •'C 
9. 38 I ,(•/2, 5 
"' '.] 9. 25 -,4/-.- 4C 
9 9 
"' 
•1C .. C) 
9 0.21 1 




~. I~ 3 ~c 






• • • • -.~/I' 5 CD • • • • • • • • n 
" • • • • 79 AC • • • • • 30 
" 
• • • • 31 w • • • • • 
" " 
® • • • • 33 
" 
• • • • • • 
A 3, -/I , - A3 • • • 
>t c 2,5/-,4 CD • • • • • • • 
c 16 
" 
• • • • • • 
c 18 BC • • • • • • 
c 19 SD • • • 
0 21 
" 
• • • • • • 
c 
" 
BD • • • • 
44 AD • • • • 
81 sc • • • • • • Be BD • • • • • • 
8b AC • • • • • 
FIGURE 5. Segregation patterns of 6 DL specificities in five beagle (1-5) and two mongrel 
16-7) dog families. 
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can allocate the haplotypes C and D of the 
dame by studying the sera negative \Vith the 
cells of the sire and positive with the cells of the 
dame, a maternal backcross (for example, DL 4 
nnd DL 5 in family 7). 
Tran~plantation experiments ha·w shovm that 
the DL-A haplotypes obtained in this \V<1Y \Vere 
mrnningful in terms of graft survival. Allografts 
(skin (23). small bowel (26). kidney (27), heart 
( 5), and pancreas (de Gruyl, unpublished 
data)) from DL-A-identicallittermates survived 
significantl:v longer than grafts from DL-A-noni-
dentical littermates. All families in Figure 5 are 
examples of the two different kinds of double 
backcross mntings described in J\tiaterial and 
~Icthod~. 
If there are two series of multiple alleles in 
the DL-A system, their genetic determinant:':! 
should occur on the same homologous chromo-
T.\HLE 3. Distribution of DL-A specificities 1, 2, 
and 3 in 100 random mongrels and 77 beagles 
DL specificities No. of mongrels" 
Ob- Expected 
served 
+ + + 0 
+ + !.58 
+ + 4.-17 
7 + 1 1.64 









Total 100 100.00 
"Mongrels" X~J, 2.27; 0.25 < 1' < 0.50. 
0 Beagle~· x2o, 4.07; I'> 0.2. 
No. of beagles11 











T.\:ULI·; 4. Distribution of DL~A specificities 4, 5, 
and 6 in 100 random mongrels and 77 beagles 
DL specificities K o. of mongrelsa 
s~e~d Expected 
+ + + 0 
+ + 6.67 




+ !! 7. ~4 
ll 31. Hi 
+ !\ 22.41 
38 10. 7!l 
Total 100 100.00 

















"Mongrels' x 2a gives a 1' << 0.001; results are not compatible 
with a. series of four multiple alleles. 
I> Beagles' x2~, 9.48; 0.001 < 1' < 0.025; re~ults arc not com-
patible with :o.erie~ of four multiple allele.~. 
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T.-1.BLE 5. DL-A haplotypes found in unrelated 
genotyped beagles (80 haplotypes) and mongrels 
(36 haplotypes) 
Specificities on haplotypes of series 
:Ko. found 
1;t 2od 
DL I DL 4 2 
DL I DL 5 3 
DL I DL H 2 
DL I G 
DL 2 DL 4 
IJL 2 DL 5 10 
DL 2 JlL 6 
DL 2 I 
DL 3 JlL 4 I 
DL 3 DL 5 2 
DL 3 J)L () 2 
DL 3 II 
DL 4 20 
DL 5 9 
DL r; 20 
20 
Total 110 
some. In famil~- 3 (Fig. 5) DL 3 from the postu-
lated first .'3eries and DL 5 from the postulated 
,;;econd .::erie;;; are part of the same paternal hap-
lotype. The results, which do not fit the rules 
cxphined in ~Iaterial :md Methods, are encir-
cled. 
The rrproducibility of the test, the fact that 
familie~ 1~5 were onl~- tested once, and the fact 
tlutt ~orne specificities are recognized by only 
one anti::.:erum mi::;e the possibility that these 
ahbC'ntnt re~ult.s in family typing were caused by 
,-.erologicnl error.-3. In the SO dog families studied, 
oue pos:'ible example of recombination in the 
chromo:'!omal DL-A region has been found. The 
arwly:'i::' of this beagle family will be reported 
after more exten:::;i\'8 studies. 
Table 5 summarizes the DL-A haplotypes 
found in beagles and mongrels. Ko doublets \Vere 
found. Table 6 gives an example of the type of 
investigation employed to study the possible 
Mcndeli;m character of the different specificities. 
The low x" Yalue shmvs an excellent fit with the 
null hypothe~is that the studied specificity is a 
dominant .1\iendelian factor. All the other speci-
ficities studied had similar low x" value in this 
test. 
DISCUSSION 
In man (1), mice (15, 19), and probably rhe-
sus monkeys (3), the genetic determinant.-; of 
T.-\.BLJ.: 6. Analysis of ~ o. of negative littermates 
in families of mating type DL 3+ /DL 3- X 
DL 3-/DL 3-" 
Litter 
1~0 • of 1 
. fam- j---------
:Ko. of negatives 
\"ariance 
Observed Expected slze ilies I 
-~- ---~ ~~- -~-
2 •) •) 
5 2 3 
6 2 
7 5 
8 2 8 
9 5 














"x'(l DF) ~ (R, - E,)/V, ~ 0.33. 
the major histocompatibility system are de-
fined by multiple alleles of two segregant series 
oecupying two closely linked loci or subloci. Our 
results in canine tissue typing suggest a similar 
genetic structure for the DL-A system. :.Jever-
theless, other explanations are possible. The 
methods tt.'3ed in this study have been critically 
discussed by Andresen et al (2), }Ii and ~dor­
ton (10), and Ceppellini eta!. (6). Most of their 
comments on numbers of tested subjects, sero-
logicnl inconsistency, and gametic associations or 
linkage disequilibrium can be applied to the re-
sults described here. The e\·idence for the first 
.~erirs of multiple alleles in the DL-A system 
appears to be sufficient. Evidence for the second 
serif'S i::; still preliminary. Although the analysis 
of DL -L DL 5, and DL 6 indicates that there is 
probably another series of multiple alleles be-
sicks the first series. an exact analysis is ham-
pered by the fact that the specificities DL 5 and 
DL G are probably not monospecific. In fact, DL 
5 and DL 6 haYe a high positiYe association in 
mongrels and DL 2 and DL 5 are highly posi-
tiYely associated in both dog populations. 
Cro~s reactiYity and cytotoxicity-negatiYe ab-
:::orption-positive phenomena (28) haYe not yet 
been studied in the dog. They complicate the 
df'finition of monospecificity and the determina-
tion of the exact number of (sub)loci of a major 
hi.':'tocompatibility system. Additional eYidence 
for the existence of two series of multiple alleles 
will perhaps be aided by the testing of more 
clogs, planned immunisations, and absorption 
studies. Only the full analysis of the most prom-
ising antisera was given here. The 10 antisera 
with a higher frequency of positive reactions, 
which include the shorter specificities described 
in this article, are particularly interesting since 
they might provide an experimental model to 
study the biological significance of systems like 
the 4a/4b system in humans (20, 21). Differ-
ences in the gene frequencies of some of the six 
.specificities in beagles and mongrels are perhaps 
analogous to differences in HL-A gene frequen-
cies in various human ethnie group~ (13). These 
results are in contrast to what is known ubout 
the gene frequencies of erythrocyte groups in 
dogs (17). The differences could. howevf'r, aL~o 
be explained by the small sample size, genetic 
drift in. a limited population, or selective breed-
ing (7). 
The biological significance of major histocom-
patibility loci is not yet known. The dog appears 
to have a high degree of polymorphism in his 
major histocompatibility system. The possible 
existence of two subloci in the DL-A system and 
of varying DL-A gene frequencies in different 
dog breeds suggest a high degree of .5imilarity 
between HL-A and DL-A. Thus, the dog seems 
suitable for the exploration of current clinical 
and biological problems associated \vith histo-
compatibility genetics. 
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CHAPTER4 
The following chapter is reproduced by permission of Grune & Stratton, Inc., 
New York. It was published before in Transplantation Proceedings, 1973, 5, 
311-315. 
Analysis of the DL-A System in Families and Populations 
of Healthy and Diseased Individuals 
By H. M. Vriesendorp, J. D'Amaro, J. A. van der Does, D. L. Westbroek, and R. B. Epstein 
A LARGE body of information is avail-able on major histocompatibility sys-
tems of man, rhesus monkey, and small 
rodents. 1 In our laboratories studies were 
initiated to obtain a comparable amount of 
knowledge of dog histocompatibility anti-
gens. In previous reports we have demon-
strated that the dog as the above mentioned 
mammalian species, possesses only one 
major histocompatibility system (DL-A), 
possibly consisting of two linked series of 
multiple alleles.2•3 The purpose of this pa-
per is to present a progress report on DL-A 
antigen recognition. The occurence of DL-A 
antigens in two different dog populations, 
in dog families and in groups of dis~ased 
dogs will be reported and compared to 
analogous data obtained in human histo-
compatibility studies. 
MATERIALS AND METHODS 
Animals 
Unrelated mongrel dogs originating from all 
parts of the Netherlands (approximately 36.200 
km2) were obtained from three different dog 
handlers. A population of unrelated beagles was 
selected from animals belonging to six different 
breeders. When pedigrees were not available, 
only those animals were included .in the analysis, 
which were born on different days .. Blood samples 
of dogs with leukosis, diabetes mellites, or hemo-
lytic anemia were obtained through the courtesy 
of the Small Animal Clinic of the State University 
Utrecht, The Netherlands (Head Professor Dr. 
G. H. B. Teunisse). Samples of a control group 
were obtained from animals visiting the same 
clinic for nonmalignant, non endocrine, mostly 
surgical disorders. As of yet pathologic studies 
Laboratory of Experimental Surgery, Medical 
Faculty Rotterdam, The Netherlands. 
Department of Immunohematology, Leiden Uni-
niversity, The Netherlands. 
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of biopsy or autopsy material of the leukosis dogs 
have not been completed. Therefore the more 
general term "leukosis," will be used instead 
of the more precise one "malig,~ant lymphoma," 
since some of the animals might have been suffer-
ing from one of the rarer canine leukocyte ma-
lignancies.4 
Test, Sera, lmmunogentic Methods 
A microcytotoxicity test, with a reproducibility 
rate of over 90% was used. ThC test, the produc-
tion of typing sera and the immunogenetic meth-
ods used for the definition of alleles and series 
have been described previously.2.3.5 
Seventy to ninety different allo antisera, most of 
them raised in intrasib immunizations (skingrafts 
or subcutaneous leukocyte injections) have been 
used to type the blood samples. All samples were 
tested twice on two different days, except the ones 
from leucosis animals, which were typed only 
once. To investigate the relationships between 
alleles of different series, gametic associations 
(.6.) or linkage disequilibrium parameters were 
computed from random phenotypes using the 
formula given by Ceppellini.6 X2 values of hetero-
geneity were calculated, following Mather,7 to 
measure the significance of the difference in 
gene frequencies between the two dog populations 
investigated. 
Nomenclature 
Twelve specificities have been defined belonging 
to two linked series of alleles. They have been 
labeled DL 1-12 (Table 1}. It is one of the pur-
poses of a Worshop on Canine Immunogenetics 
in November 1972 in Rotterdam to reach inter-
national agreement on a common nomenclature 
for DL groups, which can be used instead of 
local group designations. DL 7 is sometimes 
labeled DL 7 (long) since the shortest serum of 
the group has only been available for the second 
part of the described studies. 
Absorptions 
Some of the DL 1 and DL 4 sera were used in 
absorption experiments and appeared to be "oper-
ationally monospecific,''8 using ten different posi-
tive cell samples. Absorption studies of the 
other specificities are in progress. 
Table 1. DL-A Gene Frequencies and !::J. values in Population of Unrelated Dogs 
FIRST SERIES GENE FREQUENCY NUMBER OF ANTISERA 6 VALUES BETWEEN DL 





































The phenotypes of 112 unrelated mon-
grel dogs were used to investigate whether 
the distribution of the groups of the two 
series obeyed Hardy-Weinberg equilibrium. 
In both series reasonable fits with expecta-
tions based on Hardy-Weinberg equilib-
rium were obtained. In the first series no 
triply positive animals were observed. In 
the second series two triplets were found. 
In both series the frequency of as of yet 
unidentified alleles was approximately 0.4. 
In backcross fam"ilies the observed segrega-
tion ratio's for every DL group were 
compatible with the ones expected of auto-
somal dominant Mendelian characters.9 The 
amount of polymorphism of the DL-A sys-
tem which can be identified now is 49 
different haplotypes, 1225 different geno-
types, and 441 different phenotypes. 29 of 
the 49 possible different haplotypes have 
been found in the dog family studies so 
far. No discordent haplotypes of "doub-
lets" were found. Antigen combinations 






4 DL 2 - DL 6 0. 0 18a 
DL 3 - DL 12 0. 0 18b 




DL 9 - DL 6 0.033c 




computed from the unrelated phenotypes 
{Table 1) were also found more often in 
the family studies as a haplotype than 
haplotypes of antigen combinations for 
which none significant 6 values were 
found. A strict comparison of 6 values 
from unrelated phenotypes to 6 values 
from family studies is not possible, because 
of the low number of families studied ( 45) 
and the high amount of beagle families 
among them (30). Three examples of cross-
ing over between the two DL-A series 
were found. Two occured in a maternal, 
one in a paternal DL-A chromosome. The 
recombination frequency in the studied 
material was 3/410 = 0.007. Since it has 
been shown that DL-A disparity is com-
monly reflected in MLC reactivity/0 it will 
be of great interest to perform mixed 
lymphocyte cultures in these recombinant 
families. Sera of 17 female dogs, who had 
given birth to a litter, ($.wks before test-
ing, were tested for the presence of anti-
bodies against the cells of 34 random dogs, 
including the sire of the litter. Three or 
17% appeared to be positive. 
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Relevance For Transplantation 
Figure 1 depicts the influence of pros-
pective DL-A typing on some allograft sur-
vivals in littermate donor-recipient pairs. 
DL-A identical skin? heterotopic small 
bowel,'' orthotopic small bowel (L. van 
Stekelenburg, unpublished observation), 
pancreas/2 kidney/3 orthotopic heart,14 
and uterus (F. J. van Assen, unpublished 
observation) allografts all survive signif-
icantly longer. The longest survivals have 
been noted in those experiments in which, 
during transplantation of a DL-A-identical 
donor organ, bloodtransfusions were 
given. New experiments have been initiated 
in an attempt to exclude a random asso-
ciation between blood transfusions. and 
long survival times in DL-A-identical do-
nor-recipient combinations and to explore 
other factors which could be of importance 




kidney ~ 43.0 lheter) I 
15,3 
small bowel ~ 45,3 {heter.) .. I 
10,5 
pancreas r- 46,4 (heter) I 
17,4 
heart ~ (orthot) 
DL-A identical allografts have been noted 
in skins, which is analogous to findings in 
other species. They might be caused by 
strong, non-DL-A, polymorphic differen-
tiation antigens of skin grafts or occur as 
a peculiarity of an initially nonvascularized 
graft. Kidney and small bowel allografts 
from unrelated DL-A compatible beagles 
(no "full-heusen identical combinations in 
unrelated donor-recipient pairs have been 
found yet) survive significantly longer than 
mismatched organs, though not as long as 
DL-A-identical grafts from littermates (Ref. 
11, Obertop, unpublished data). 
Comparison of Two Dog Populations 
Table 2 illustrates that the genefrequen-
cies of most DL-A groups in a mongrel 
dog populuation (N = 114) were signif-
icantly different from the ones found in a 
beagle population (N = 74). 
~ 1 or 2 DL-A haplotype differences 
0 0 
111,2 
small bowet"' I 1221 
{orthot) t= == = = = = == = = ======·======= = ==================== ==j 
0 10 20 30 40 50 60 70 80 90 100 110 120 130 
days 
Fig. 1. Mean survival times of different allografts in identical and nonidentical beagle 
littermates (without immunosuppressive therapy). 
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N.S. = not significant 
DL-A Groups and Disease 
DL-A7 (long) appears to occur more often 
than expected in leucosis dogs. DL-A 3 and 
DL-A 7 (long) are more frequent in dogs 
suffering from diabetes mellites (Table 3). 
The significance of these findings disap-
pears however, when the p values are cor-
rected for the number of comparisons 
made, as suggested by Bodmer. Future stu-
dies will have to determine the real signif-
icance of the correlations found. 
Linkage 
Independent segregation of the DL-A 
system and the dog coat color loci B, E, 
S and T (15) have been found. This ex-
cludes close linkage between these coat 
color systems and the DL-A system. 
DISCUSSION AND CONCLUSIONS 
A striking similarity between the human 
HL-A system and the canine DL-A system 
has been observed. Both are extremely 
polymorphic and consist of two series of 
multiple alleles. The recombination fre-
quency between the two series in the two 
species is similar (0.007 compared to 
0.00816) Roughly the same percentage of 
postpartum sera are found to be positive 
SIGNIFICANCE LEVEL 





0.025 <P <0.05 
N • S • 
0.001 <P <0.005 
N • S • 
for alloantibodies in both species17 Some 
haplotypes of major histompatibility anti-
gens occur more often than would be ex-
pected on a basis of random associations 
between antigens in both species. This link-
age disequilibrium between antigens of the 
two series can be explained either by recent 
mutations in the DL-A and HL-A system, 
either by selectional forces favouring spe-
cial antigen combinations. 1 The observed 
variations in DL-A genefrequencies be-
tween the two dog populations are compar-
able to the ones found between different 
human ethnics groups. The relevance of 
the DL-A system for histocompatibility 
has been clearly demonstrated in related 
donor-recipient pairs and also in as of yet 
small series of unrelated animals. Obvi-
ously the suggestive correlations, which 
have been observed between certain DL-A 
antigens and diseases should be confirmed 
in further studies. If this appears to be the 
case, new investigations into for examnle 
leukosis susceptibility might be profitable. 
The observed correlations in dogs are 
again comparable to human data in which 
several tentative correlations between spe-
cial diseases and HL-A antigens were 
found 1 
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Table 3. Significance Levels* of Difference of DL-A Gene Frequencies in Individuals 
With Special Diseases Compared to a Control Group (N =51) 
Dl GROUP LEUCOSIS DIABETES MELLITES AUTOIMMUNE HEMOLYTIC 
( N • 12) ( N •21 ) ANEMIA (N•8) 
1 0. 81 0.72 0.86 
2 0. 21 0.28 0.34 
3 0.05 < p <0.1 O.OI<P<0.05 0. 2 3 
7 ( I ong) 0.005< p <0.01 0.01 < p <0.05 0.20 
9 0. 5 <P<0.75 0. 14 e.o8 
10 0. I 0 <P<0.25 0.26 0.40 
4 0.05 < P <0. I 0.02 0.30 
5 0. 5 <P<0.75 0. I <P<0.25 0.05 
6 0.39 0.26 0.75 
8 0. 19 0.08 I. 
11 0.43 0. 38 0.55 
~Determined with x2 test (one degree of freedom) or Fisher's 
exact test on 2 x 2 table. 
The striking similarities, which have 
been found between the DL-A and the 
HL-A system make the dog a very appro-
priate animal for future studies into clin-
ical and biologic problems of histocompat-
ibility research in a randomly bred species. 
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The mongrel dog is an outbred species 
which lives in close proximity to man. It 
shares the human habitat, diet and expo-
sure to microbiological, physical and chem-
ical pathogens. Many human diseases have 
a canine equivalent (Cornelius 1969). The 
dog could therefore provide a good experi-
mental model to study these diseases. It 
could also be useful for the extrapolation 
of new biological concepts, developed in 
inbred murine strains, to a readily avail-
able outbred species before they are ap-
plied to the human. In this respect the dog 
could be of benefit for studies in transplan-
tation and tumor immunology, immuno-
pathology and population genetics if suf-
ficient "basic" parameters such as histo-
compatibility antigens, red cell antigens 
and other genetical markers could be de-
termined in this species. It is felt that a 
joint effort by research workers engaged in 
these fields was optimally suited to the as-
sessment of the current state of our know-
ledge of the dog and to the determination 
of important future lines of research. 
Therefore a workshop and symposium on 
canine immunogenetics was held at the 
Medical Faculty in Rotterdam, The 
Netherlands from November 5-16, 1972. 
The Department of Immunohaematology 
of the Leyden University Medical Centre 
and the Laboratory of Experimental Sur-
gery of the Medical Faculty Rotterdam 
shared the organizational responsibilities. 
The meetings were sponsored by the Inter-
national Transplantation Society. 
This is a report of the preliminary ana-
lysis of the data obtained during this work-
shop. The genetic systems which can cur-
rently be analyzed in dogs by immunologi-
cal or electrophoretic techniques will be 
described and discussed. It appears that 
several important polymorphic systems 
such as lymphocyte antigens, erythrocyte 
antigens, red and white cell enzymes, se-
rum proteins and digestive tract antigens 
can be reasonably well defined in dogs. 
Immunoglobulin and immune response 
markers were not studied during this work-
shop. They remain some of the most im-
portant still unidentified genetic markers 
in the dog. This report will be followed by 
( 1) a discussion of the most evident appli-
cations of this new knowledge and ( 2) 
abstracts of papers given during the sym-
posium. 
Material and Methods 
The investigators and the systems which 
they studied during the wo·rkshop are listed 
in Table 1. 
Dogs: 100 unrelated mongrel dogs (60 
males and 40 females) were obtained from 
three different dog handlers, who collected 
animals from various parts of the Nether-
lands ( approx. 36,200 km2). Physical exa-
mination placed most animals between 2 
and 5 years of age. Eighteen families with 
a total of 101 pups were available for test-
ing. All parents) except 4 sires which were 
unknown, were included in the random 
sample. Fifteen families were from mon-
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Table 1 
Genetic systems investigated during workshop 
System Investigators 
DL-A Albert, Cabasson, van der Does, Epstein, Erikson, Flad, Ham-
mer, Largiader, von Loringhoven, Saison, Serrou, Schnappauf, 
Templeton, Uhlschmidt, Vriesendorp 
Tumor sera Epstein 
Hammer Xenograft sera 
Lymphocytotoxins recognizing 
factors other than DL~A 
Mixed lymphocyte cultures 
Red cell antigens 
Lang, Albert, Erikson, Flad, von Loringhoven, Schnappauf, 
Templeton, Vriesendorp (sera supplied by Lang and Cabasson) 
van der Does, Templeton 
Digestive groups 
Bull, van der Does, Swisher, Vriesendorp, Zweibaum 
Zweibaum 
Red cell enzymes 
White cell enzymes 
Serum proteins 
Los, Meera Khan, Saison 
Los, Meera Khan 
Bernini, Saison 
Feltkamp Auto immune antibodies 
ABO antibodies Vriesendorp, Zweibaum 
grel dog, two from beagle and one from 
Labrador parents. No neonatal deaths have 
occurred. The sex ratio (male/female pups) 
was 1.5: 1, which was the same as in the 
sample of unrelated dogs ( 60: 40). Reports 
of high sex ratios in dogs have been pub-
lished previously (for a review see Burns 
& Fraser 1966). The !00 unrelated dogs 
and 80 pups from the 18 families were 
tested by most workshop participants. 
Those dogs and 21 additional pups from 
the same families were investigated for red 
and white cell enzyme polymorphisms, for 
digestive group antigens and their "natural 
occurring antibodies and for DL-A 
groups by a restricted number of sera (The 
Rotterdam-Leyden sera). Albumen poly-
morphism and the presence of autoimmune 
antibodies were investigated m a limited 
number of workshop dogs, 96 and 169 
animals respectively. 
Methods: A manual of methods used dur-
ing the workshop is available upon request 
from D. L. Westbroek, Laboratory for Ex-
perimental Surgery, Medical Faculty Rot-
terdam, The Netherlands. Briefly, a one or 
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two stage microcytotoXICI ty test was used 
for lymphocyte typing. Red cell typing was 
performed with a macroscopically read 
droplet method, employing fresh auto-
logous serum as cell suspension medium. 
All reagents were used in hemagglutina-
tion, except the CEAl (old A) and CEA2 
(old A 1 ') reagents which were also read 
for hemolysis. An indirect antiglobulin 
(Coombs) test was performed with those 
cells which were negative in hemagglutina-
tion and hemolysis for the latter two rea-
gents. The presence of digestive tract anti-
gens and their "natural occurring" anti-
bodies was determined with an indirect im-
munofluorescent technique using previous-
ly selected and defined test sera and a pa-
nel of dogs with established digestive tract 
antigens. Antibodies against human ABO 
antigens were sought for in absorption tests 
or comparative titration studies. "Auto-
immune" antibodies in dog sera against 
nuclear factor, smooth muscle, mitochon-
driae or gastric parietal cells were sought 
using a 1-to-20 serum dilution in an in-
direct immunofluorescent technique on rat 
kidney and gastric tissue. 
Analysis of results: The test results of the 
unrelated animals were analyzed with the 
help of computer programs. In one group 
of programs (so called "cluster" and "tri-
angle'' programs) results of all the differ-
ent reagents/techniques were compared 
pairwise in two-by-two contingency tables 
(van Rood & van Leeuwen 1963). 
Chi squares for independence and alle-
lism (Andresen et al. 1963) and correlation 
coefficients were calculated. Gene frequen-
cies were determined by the square root 
method, GF = 1- V (1- f), in which f 
is the population frequency of the factor 
under investigation. A second program, 
developed by J. D' Amaro and G. J. v. d. 
Steen called CHECK, was used to test the 
population genetics of defined DL groups. 
Gene frequencies were calculated using the 
maximum likelihood method {Yasuda & 
Kimura 1968). Checks on Hardy-Weinberg 
equilibrium were also made. Linkage dis-
equilibrium parameters or deltas were cal-
culated between the factors of the two se-
gregant series of the DL-A system (Mat-
tiuz et al. 1970). 
Family and linkage studies for this re-
port were done manually. A more ad-
vanced computer analysis such as a factor 
analysis (see Albert et al., abstract 5) and 
a search for the occurrence of loose link::ige 
between markers will be done in the near 
future and will be the subject of a second 
paper on the workshop data. 
Results 
DL-A 
Serology: 419 different sera were used in 
the one or two stage microcytotoxicity test. 
The latter was the more sensitive. The 
reproducibility rate of the test was not di-
rectly investigated during the workshop. 
Previous experience has shown that it is 
approximately 90 %. This is in accordance 
with the best positive associations found 
between sera from two different investi-
gators (Soll78, a Seattle serum and 
S14032, a Rotterdam serum) in the work-
shop, which showed a total of 11 discre-
pant ( -/ + and + 1-) results. 
Computer analysis 1: From the printouts 
of the "cluster'' and "triangle'' programs a 
search was made for positively correlated 
sera from different investigators. Most of 
the previously defined DL clusters (Vrie-
sendorp et al. 1972a, 19731 were confirmed 
by the workshop participants (Table 2). 
All clusters which did not include DL spe-
cificities had high population frequencies 
except one, which became the DL 14 clus-
ter. In the light of the available knowledge 
on the dog and on other species, a high 
population frequency for a serum is com-
monly associated with the presence of an~ 
tibodies against more than one antigen. 
Nomenclature: Since most of the DLgroup 
were confirmed and had the lowest pop-
ulation frequencies (and thus a higher 
probability of being monospecific), it was 
agreed to use the Rotterdam-Leyden no-
menclature until the next workshop, when 
perhaps more definite symbols can be as-
signed to antigens by using a DL-A prefix 
followed by a number, instead of the cur-
rent DL number. The Rotterdam-Leyden 
groups number from DL I to DL 13. The 
new cluster found in the workshop with 
a low population frequency (S 01005. 
S 010024, and S 01042) has been named 
DL 14. Absorption experiments for all DL 
groups are m progress. 
Computer analysis 2: The program 
CHECK tested the fit of the specificities, 
DL I. 2, 3. 7, 8, 9, 10 and 4. 5+ 13,5-13, 
6, 11, 12, 14 as two separate segregant 
series of alleles. The antigen DL 5+ 13 was 
assigned as positive, when both DL 5 and 
DL 13 were positive. The antigen DL 5 --
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Tab/, 2 
Two x two tables of results of single workshop sera and previously reported DL groups 
Number of 
Rotterdam- Cells of tv.ro X two table 
DL group Leiden sera Workshop 
available for serum 
group 
-I- -I+ +I- +I+ 
recognition 
DL1 4 s 01130 85 9 0 3 
DL2 6 s 01146 52 36 1 9 
DL3 4 s 01159 18 30 5 46 
s 03011 11 35 0 52 
s 10008 36 10 11 41 
DL4 6 s 01036 47 23 6 23 
s 01051 57 13 1 28 
s 01056 53 17 4 25 
s 01078 52 17 6 22 
s 01091 52 16 8 22 
s 01129 53 15 7 23 
s 01178 64 5 4 25 
s 03012 50 20 6 23 
s 04006 29 39 0 28 
DL 5 6 s 01033 33 23 3 40 
s 01035 26 30 5 38 
s 01039 28 27 3 37 
s 07019 31 24 4 40 
s 07020 28 17 3 38 
DL6 4 s 01053 75 12 4 8 
s 03016 64 22 2 10 
s 07004 60 26 1 10 
DL7 5 s 01290 43 39 3 15 
s 01147 62 6 8 12 
s 03014 47 38 5 11 
DL 8 3 s 03009 85 9 0 5 
DL9 6 s 01051 52 25 6 15 
s 01057 55 22 3 18 
s 01058 62 17 7 14 
s 01128 64 22 3 17 
s 01129 58 18 1 21 
s 03003 59 18 4 17 
s 07002 61 15 3 18 
DL 10 5 s 03004 42 35 1 21 
s 07027 60 16 7 15 
DL 11 2 (extra reactions s 07024 44 30 5 20 
of DL 2 sera) 
s 01150 63 10 9 13 
DL 12 2 (extra reactions s 03012 47 31 8 13 
of DL 9 sera) 
s 03014 42 33 8 13 
s 07011 42 37 7 12 
DL 13 4 none 
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Table 3 13 was assigned as positive, when DL 5 was 







































of DL groups The maximum likelihood estimates of 
'First' 'Second' the gene frequencies are listed in Table 3. 
series series Random phenotypes of DL groups of the 
"first" segregant series are compatible with 
0.0152 DL4 0.1842 Hardy-Weinberg equilibrium (Table 4). 
0.0517 DL 5 + 13 0.1629 No triplets were found. The sample is 
0.3022 DL 5- 13 0.1002 
small, however, and no definite conclusions 0.1125 DL 6 0.0564 
0.0259 DL 11 0.1507 can be drawn. Table 5 shows the observed 
0.1242 DL 12 0.1086 and expected phenotypes of DL groups of 
0.1143 DL 14 0.0350 the "second" segregant series. Two triplets 
0.2540 Blank 0.2020 were found (DL 4, DL 5- 13, DL 11 and 
DL4,DL5-13,DL12). 
Table 4 
100 random phenotypes.of DL groups of first series 





DL 9 1 
DL 10 0 
Blank 1 








DL 9 9 




DL 10 3 
Blank 7 
DL 9 0 
DL 10 1 
Blank 3 
































































Total 7.673 (d.f. ~ 4) 
0.1 < P< 0.2 
1) 2) 3) 4) indicate that results are pooled to obtain sufficient expectations for analysis. 73 
The P value for this X2 value is not com-
patible with a series of alleles in Hardy-
Weinberg equilibrium. When DL 12 was 
not included in this analysis a x2 value 
with a P between 0.1 and 0.05 was obtain-
ed. Omitting DL 4 or DL 5- 13 did not 
improve the fit. 
Family studies: In the 18 families studied, 
no discordant haplotypes with two or more 
DL groups from one series were found. DL 
groups of the same series were inherited in 
repulsion. DL groups from the two series 
segregated as haplotypes. The most com-










DL 5 - 13 
DL 5- 13 
DL 5 - 13 
DL 5 ·· 13 
DL5--13 
DL 5 ·· 13 
DL 5 + 13 
DL 5 + 13 
DL 5 t 13 
DL 5 + 13 












100 random phenotypes of DL groups of second series 
Group 2 
DL 5 - 13 




















































































































Total 21.531 (d.f. ~ 7) 
0.01 < p < 0.001 
Total X2 of the same analysis without DL 12 = 10.319 (d.f. = 5) 
0.05 < p < 0.1 
1) 2) 3) etc. indicate that results are pooled to obtain sufficient expectations for analysis. 
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Table 6 
Common combinations of DL groups 
Group Group Observed first series second series 
DL 2 DL 5 - 13 5 
DL 2 DL6 4 
DL3 DL 11 20 
DL 7 DL5-~13 10 
DL 7 DL 12 7 
DL9 DL4 13 
DL 9 DL6 5 
DL 10 DL 5 - 13 12 
a P < 0.0005 
b 0.001 < p < 0.005 
c 0.005 < p < 0.01 
listed in Table 6. Only those combinations 
which show a delta value > 0.01 and a P 
< 0.05 are indicated. A possible example 
of crossing over between two paternal hap-
lotypes was encountered in workshop fam-
ily 004 (see also MLC paragraph). 
Possible cross reacting DL groups: Several 
of the sera in the clusters DL 3, DL 7 or 
DL 10 reacted often positively with cells 
not carrying the group recognized by the 
cluste"r. The e.xtra reactions always occur-
red with cells positive for DL 3, 7 or 10. 
This could be explained by the existence of 
antibodies which crossreact with DL 3, 
DL 7 and DL 10, all of which are from the 
first segregant series. This hypothesis is sup-
ported by the fact that most of those sera 
were raised using donor-recipient combina-
tions which differed in only one antigen 
per series (i.e. littermates with one DL-A 
haplotype difference). Appropriate absorp-
tion studies to investigate this are in pro-
gress. Previous reports ( V riesendorp et al. 
1972a, 1973) have included DL 5 in the 
second segregant series of the DL-A sys-
tem. D>tta obtained during the workshop 
showed that DL 5 could be split into at 
Expected z2 Delta 
1.554 7.63SC 0.013 
0.580 20.123" 0.016 
8.945 13.662" 0.048 
2.100 29.709a 0.037 
2.347 9.220b 0.017 
4.148 18.882" 0.039 
1.386 9.414b 0.014 
3.539 20.227 a O.oJ8 
least two parts. Part one (DL 5 + 13) con-
sisted of reactions with cells positive for 
DL 5 and DL 13. Part two (DL 5- 13) 
consisted of cells positive for DL 5 and ne-
gative for DL 13. Both parts appear to be-
long to the second segregant series. This 
could be an example of cross reactivity 
between DL groups in the second segre-
gant series. 
Lymphocytotoxins recognizing factors 
other than DL-A 
Several sera consistently showed segrega-
tiori patterns in families which were dif-
ferent from the ones observed for DL hap-
lotypes. The results of two of these sera 
are summarized in Table 7. SerumS 14113 
in the shortest part of a cluster of positively 
associated sera from different centers 
( S 04003 Ulm, S 01110 Seattle, S 14113 
Columbus). The correlation between 
S 14060 and S 14113 in unrelated animals 
suggests an allelic relationship since the 
sera are negatively correlated (x2 for inde-
pendence 4.04) and have a low z2 for al-
lellism, 0.99. In the 18 workshop families 
no double backcross matings were available 
to check this hypothesis of allelism. 
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Table 7 
Lymphocyototoxins, determining factors other than DL-A 
Number of expected No DL-A Serum Source Gene segregation positive siblings/ 
number frequency (No. of families) Number of observed positive siblings 
s 14060 Cabasson 0.1652 4/5 26/30 
(Montpellier, France) 
s 14113 Lang 0.1125 6/6 22/22 
(Columbus, U.S.A.) 
Sera from dogs with regressing 
Transmissable Venereal Tumor (TVT) 
(see Epstein & Bennet, abstract 10) 
Four early regressor sera were included in 
the workshop analysis. All appeared to in-
clude DL 6 and DL 7. This confirms the 
findings of Epstein & Bennet that tumor 
survival is influenced by the DL-A pheno-
types of the recipients and provides in-
direct evidence for the presence of DL 6 
and DL 7 on TVT cells. 
Dog and Fox 
During the workshop two samples of fox 
blood were tested for DL groups. Earlier 
findings (Vriesendorp 1972b) were con-
firmed. Fox cells show polymorphism with 
dog allo antisera from prolonged immu-
nization schedules, especially in the more 
sensitive two stage cytotoxicity test. No 
positive reactions were found with sera 
with a low population frequency in a one 
stage test. 
Two sera in the workshop were pro-
duced by dogs which had rejected a fox 
skin graft (see Hammer, abstract II). Both 
showed reactivity patterns in the one stage 
cytotoxicity test with dog lymphocytes 
which included DL groups. They were 
not tested in the two stage cytotoxicity 
test. 
Mixed Lymphocyte Cultures ( MLC) 
MLCs in dogs follow the patterns of hu-
man, rhesus monkey and mouse MLCs, 
since lymphocytes of sibs, which are iden-
tical for the serologically defined major 
histocompatibility antigens, do not stimu-
Table 8 
DL-A haplotypes of workshop family 004 
Dog· 
DL groups 
DL genotypes DL hapoltypes 
DL 31 DL sj DL 7 jDL IOjDL 12 
00400 (dame) + + + 3,5/10,5 C/D 
00401 (sire) + + + + 7,12/10,5 A/B 
00402 + + + 3,5/10,5 B/C 
00403 + + + 3,5/7,5 AjB/C 
00404 + + + + 10,5/7,12 AID 
00405 + + + 3,5/10,5 BjC 
Repeatedly no stimulation in all possible two-way MLCs between 00402, 00403 and 00405. 
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late (Templeton & Thomas 1971, van der 
Does et a!. 1972). 
The technique, however, is more diffi-
cult and less reproducible in the dog. Two 
exceptions to serotypic and MLC identity 
have been found, one by Templeton, where 
there was no stimulation between sibs that 
were serologically non identical, and the 
other in a workshop family which had an 
offspring in which a recombination be-
tween the first and second series occurred. 
The difference for the antigens DL 7 and 
DL 10 between this dog (a, b/c) and sibs 
(b/c) repeatedly did not give rise to stimu-
lation in MLC (Table 8). These observa-
tions could represent the segregation of a 
locus (or loci) linked to, but distinct from, 
DL-A which determines MLC reactivity. 
Autoimmune Antibodies in Dogs 
No ar~ 1·ibodies against gastric parietal cells 
and mitochondria were found. Table 9 
lists the positive findings for anti nuclear 
and anti smooth muscle antibodies. The 
sex ratio in that group of dogs is not signif-
icantly different from the one found in the 
dogs without autoimmune antibodies. Di-
gestive tract group X appeared to be pre-
sent in all dogs with antinuclear antibodies. 
CEA 2 (old erythrocyte antigen A 1) and 
CEA 8 (old He) were present in 8 out of 9 
and 7 out of 9 animals carrying autoim-
mune antibodies, respectively. DL 12 was 
the only DL group which occurred signi-
ficantly more frequently in these dogs, 
compared to a control group of unrelated 
animals (N = 72) without autoimmune 
antibodies (x2=5.12, P (corrected for the 
number of comparisons made) between 
0.05 and 0.025). 
Canine Erythrocyte Antigens 
Serology 
Twelve sera were used to define the cur-
rently known canine erythrocyte groups in 
the workshop dogs (see S. N. Swisher & 
Young 1961, Swisher & Bull, abstract 2). 
Eleven previously unanalyzed anti ca-
nine erythrocyte sera from other investiga-
tors were also included. Their results ap-
Table 9 
Presence of autoimmune antibodies in sera of workshop dogs 
Antinuclear 




bodies First series I Second series 
c 04000 female + 3, 10 4, 12 
c 07401 male ± 3,- - -
c 03101 male ± 3, 10 -, 12 
c 04101 male ± + - - 4, 12 
c 00705 female + 3, 7 5-13, 12 
c 00704 male + 3,- -, 12 
c 00903 male + -, 10 4, 12 
c 03901 male + 3, 10 -,II 
c 01704 male + -
' 
9 6,,-
c 01705 female ± 3, 9 6,-
c 05301 male ± 3, 10 5-t-13, -
c 00106 male ± 3, 9 4,-
c 04800 female ± 2, 3 5-13, 12 
Sex ratio male/female = 9 : 4 
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peared to fit in with the already' known 
groups. Some were polyspecific and pro-
bably also contained extra antibodies 
against undefined canine erythrocyte anti-
gens. 
Population Frequency and Family Studies 
Table 10 indicates nomenclature and pop-
ulation frequencies of the Canine Erythro-
cyte Antigens ( CEA) studied in this work-
shop. CEA 3 (old B) was not found in 
this sample of Dutch unrelated dogs. CEA 
4 (old C) and CEA 6 (old F) had a high 
population frequency. They did not segre-
gate in the workshop families. CEA 1, 2, 5, 
7 and 8 (old A 1, A 2, D, Tr and He) se-
gregated as codominant Mendelian factors. 
ABO related systems in dogs: As early as 
1910, von Dungern & Hirschfeld reported 
the occurrence of anti human A and anti 
human B antibodies and "ABO like" anti-
gens in many species including the dog; 
CEA 7 (old Tr) was closely correlated with 
the presence of digestive tract group A 
(previously shown to be human ABO A 
related, Zweibaum et a!. 1966) and the 
absence of anti human A in the dog serum. 
A rabbit antiserum against canine digestive 
group A substance was produced by Zwei-
baum. Its reactions with dog erythrocytes 
were almost completely included in the re-
action pattern of dogs positive for digestive 
tract group A and were positively correla-
ted with CEA 7. 
Digestive Tract Groups 
A tri-allelic system for antigens within and 
secreted by mucous cells of the canine di-
gestive tract has been described by Zwei-
baum & Steudler 1969 (see also Zweibaum 
& Feingold, abstract 1). "Natural occur-
ing" antibodies against the alleles A, X or 
Y have been instrumental in the discovery 
of this system. These alleles appear to have 
the same negative association in the un-
related Dutch mongrel dogs as have been 
found in earlier studies in France. Their 
gene frequencies were also similar. The se-
gregation in the families was in concor-
dance with the genetical hypothesis of 
three alleles belonging to one system. The 
relationship of this system with the human 
TablelO 






















Population frequency in 100 










a The nomenclature for blood groups in dogs is confusing. For example the A antigen in dogs is 
unrelated to the human A, while the canine Tr appears to have some relation with the human A 
(Bowdler et al. 1971). Tentative new designations are given here. Newly discovered antigens will be 
numbered 9, 10 etc. 
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erythrocyte ABO system and the canine 
erythrocyte antigen CEA 7 (old Tr) has 
been described above. No correlations with 
other CEAs or DL-groups were found. 
Red Cell and White Cell Enzyme 
Polymorphisms 
The following enzyme systems were tested 
for electrophoretically detectable variations 
in the red and white cells of the workshop 
dogs by the Leyden group. Adenosine dea-
minase (ADA), adenylate kinase (AK), 
glucose phosphate isomerase (GPI), cyto-
plasmic isocitra te dehydrogenase ( C-ID H) , 
lactate dehydrogenase A (LDH-A), LDH-
B, cytoplasmic NAD-dependent malate de-
hydrogenase (C-NAD-MDH), mitochon-
drial (M) NAD-MDH, peptidase A (Pep 
A), Pep B, Pep C, Pep D, phosphoglyce-
rate kinase (PGK) phosphoglucomutase, 
(PGM,), PGM2, PGM3, dimerictetrazo-
1 ium oxidase ( D-TO) , gl ucose-6-phosphate 
dehydrogenase (G6PD), cytoplasmic glu-
tamic oxaloacetic transaminase ( C-GOT), 
red cell acid phosphatase (on starch gel), 
6-phosphogluconate dehydrogenase (6PG 
D), NADH-diaphorase (Dia A) and 
NADPH-diaphorase (Dia B). Cellogel 
from chemetron was used as supporting 
medium, except for red cell acid phospha-
tase (Meera Khan 1971). 
The family studies indicated that the 
electrophoretic variations found for Pep D, 
PGM2, PGM3 and D-TO were due to 
the existence of co-dominant alleles at the 
autosomal loci Pep D, PMG2 , PGMs and 
D-TO. PGM2 and D-TO were predomi-
nantly red cell enzymes, PGM3 variations 
were detectable in white cells, while Pep D 
variants were discernible in white cells as 
well as red cells, making them useful as 
markers in experimental bone marrow 
chimeras. 
PGM2 , PGM3 and D-TO were found 
to be di-allelic, whereas Pep D was tri-
allelic, the gene frequency of the variant 
allele in each case being 0.010, 0.312, 0.054, 
0.260 and 0.020, respectively. The rest of 
the systems exhibited no polymorphism. 
The Guelph group studied the following 
red cell enzymes on starch gel: LDH A, 
LDH B, Pep A, Pep B, Pep C, Pep D, Pep 
E, GPI and 6PGD. Only Pep D appeared 
to be polymorphic. Their results agreed 
with those of the Leyden group. 
Serum Protein Polymorphisms 
Transferrin (Tf): Braend ( 1966) and Ste-
vens & Townsley ( 1970) have shown that 
the synthesis of canine serum transferrin is 
controlled by three autosomal co-dominant 
alleles which give rise to six phenotypes 
demonstrable by starch gel electrophoresis. 
An electrophoretic technique on thin aga-
rose gel layers was used to test the work-
shop samples. This method is easier to per-
form and gives better results than starch 
gel electrophoresis. 
Table 11 shows the electrophoretic pat-
terns of six different unrelated dogs. Sam-
ple nos. 1 (bands 2-3-4) and 3 (bands 
1-3-4) represent the homozygotes for TfB 
and TfA, respectively (phenotypes BB and 
AA). Sample no. 2 (bands 1-2-3-4) is the 
heterozygote TfA/TfB (phenotype AB). 
Sample nos. 4 (bands 1-2-3-4-5-6) and 5 
(bands 1-3-4-5-6) have been classified as 
the heterozygotes for TfA and TfB and a 
third allele TIC. The homozygote for this 
allele has not been found in the group of 
dogs examined. The sixth sample does not 
fit in with the present classification. Ap-
propriate breeding experiments are plan-
ned in order to obtain the homozygote 
TfC/TfC and to define the genotype of 
sample number 6. Table 12 gives the phe-
notype Tf distribution found in 86 litter-
mates from five different mating types. The 
results are in agreement with expectations, 


















The number of the sample and the phenotype are 
indicated at the bottom of the photograph, near 
the origin. The bands of the first five types are 
numbered from 1 to 6 in order of decreasing mo-
bility at the left side of the table. 
co-dominant alleles, TfA, TfB and TfC. 
Stevens & Townsley observed a deficiency 
of homozygotes. In the present series of 
experiments the number of AA individuals 
from six AA X AB matings is lower than 
expected. The sample is, however, not 
Table 13 
Transferrin phenotypes and gene frequency 
in 94 unrelated Dutch mongrel dogs 
Phenotypes 
Gene Tf 
No. I Ko. frequency 
observed expected 
AA 37 35" A~ 0.611 
AB 39 43" 
BB 15 13a B ~ 0.373 
AC 2 2" 
BC 1 1" c ~ 0.016 
cc 0 (0.024) 
94 94 
a Nearest integer. 
large enough to allow definite conclusions. 
Table 13 shows the Tf phenotypes and 
gene frequencies in 94 unrelated dogs. The 
observed distribution of phenotypes is con-
sistent with a series of alleles in Hardy-
Weinberg equilibrium. 
Albumen (Alb): Townsley et a!. (1972) 
have reported that albumen is polymorphic 
in dogs. A modification of their technique 
was used on serum samples from 31 un-
related Dutch mongrel dogs and 65 litter-
mates from 11 matings representing five 
different mating types. Two alleles were 
defined. One gave rise to a fast moving 
band (A) and the other to a slower band 
Table 12 
Family studies of transferrin polymorphism 
Mating types Number of 
Phenotypes and number of offspring 
families AA I BB I cc I AB I AC l BC 
AAxAA 6 
AAxAI3 6 13 23 
ABxAB 3 9 5 14 
ABxBB 3 6 6 
ABxAC 2 2 
Total 14 30 11 43 2 
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Table 14 
Family studies of albumen polymorphism 
Mating 
No. observed/expected phenotypes 
in littermates 
types 
Alb. A Alb. B 
A X B 3 0/0 17/17 0(0 
ABxAB 3 7/5 12/10 1/5 
ABx B 3 0(0 3/6 9/6 
B xAB 1 0(0 6/5.5 5(5.5 
A xAB 1 1/2.5 4/2.5 0/0 
Total 11 8/7.5 42/41.0 15/16.5 
(B). The gene frequencies in the unrelated 
individuals were Alb A=0.435 and Alb B 
= 0.564. Table 14 shows that the results of 
the family studies are compatible with ex-
pectations based on the genetic hypothesis 
of a hi-allelic system. 
Linkage 
DL-A segregation patterns in families were 
compared to the patterns of the following 
markers: the enzymes PG1vl~, PGM;{, Pep 
D, D-TO; the erythrocyte antigens A, D 
and Tr; the lymphocytotoxic sera S 14060 
and S 14113 (recognizing factors outside 
DL-A); digestive group system and the 
serum-proteins transferrin (Tf) and albu-
men (Alb). In no instance was there evi-
dence for close linkage between DL-A and 
those markers. No striking similarities in 
the segregation patterns were observed for 
other combinations of these markers for 
which informative families were available. 
These studies will be continued with more 
advanced methods of analysis and results 
will be reported later. 
Discussion 
The evidence collected during this work-
shop clearly indicates the existence of two 
segregant series of multiple alleles in the 
DL-A region (see also Albert et al., ab-
stract 5; Saison, abstract 6; and V riesen-
dorp et al. 1972a, 1973). These data and 
the significant delta values found between 
groups of the two segregant series, and the 
possible occurrence of cross reactivity be-
tween DL groups within the same series, 
indicate a striking similarity between DL-
A, HL-A (Mattiuz et al. 1970) and RhL-
-A (Gabb et al. 1972, Bainer eta!. 1973). 
The DL-A system appears to have a 
good potential for further studies in clini-
cal histocompatibility. Important serologi-
cal problems still remain to be solved. In 
human histocompatibility testing a higher 
serologic reproducibility has been found. 
Dog cells seem to be more liable to non 
specific death than human cells. Reprodu-
cibility rates will improve when optimal 
test conditions for dog cells are defined 
and when only those sera which show a 
high percentage of concordant results be-
t\-veen duplicate tests are selected for fur-
ther usc. Some groups in the "second" se-
gregant series, DL12 in particular, may 
be heterogenous, since two triplets and a 
deviation from Hardy-Weinberg equili-
brium are observed in this series. A factor 
analysis of the clusters of positively cor-
related lymphocytotoxic sera with high 
population frequencies could possibly iden-
tify the different antibody populations with-
in each cluster. 
Some of the reasons for the high reaction 
frequencies of these reagents could be the 
use of unselected donor-recipient pairs and 
long immuni:t.ation schedules. Currently 
the best available methods for the produc-
tion of tissue typing reagents are a skjn 
graft and/or lymphocyte injections between 
littermates which differ for one DL-A 
haplotype. As soon as a positive cross 
match between donor cells and recipient 
serum occurs, serum should be harvested 
(van der Does eta!. 1972, abstract 8). It 
was shown that lymphocytotoxins in dog 
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sera are not necessarily directed against 
DL-A antigens. This has also been the 
case in human tissue typing ( Dorf et al. 
1972 I. For S 14113 I see Whitacre et al., 
abstract 71 and S 0+003. immunizations 
were carried out between inbred animals. 
The donor- rC'cipient combination which 
was still available for testing- appeared to 
be DL-A identical ( Schnappauf. unpub-
lished obserYation). The prolonged immu-
nization schedules could have been favor-
able for the development of lymphocyte-
toxins against factors other than DL-A. 
Shorter immunization periods in DL-A 
identicals have not produced that sort of 
antibody 1 Westbroek et al. 1972). In future 
studies of canine histocompatibility anti-
gens. cytotoxicity patterns should be rela-
ted to a genetic system. and the histocom-
patibility effect (major or minor) of such 
a system should be identified in the appro-
priate allografting experiments before de-
finite conclusions can be reached. A bene-
ficial influence of DL--A typing on allo-
graft survival has been documented for 
bone marrow ( Epstt.>in et al. 1968) and 
many other organ allografts (for references 
see VVestbroek et al. 1972) when litter-
mates were used as donor--recipient pairs. 
Minor histocompatibility loci can now be 
analyzed in DL-A identical littermates. 
The digestive tract groups and the new 
lymphocyte specificities IS I +060 and S 
14-113) are possible candidates for such a 
function. A study of the influence of the 
digestive tract groups on the occurrence of 
graft versus host ( GVH) disease in DL-A 
identical dogs might be profitable, since an 
important part of the GVH reaction oc-
curs in the digestive tract. 
The possible existence of a separate 
MLC locus (or loci) in the dog shows that 
the dog might be closely analogous to 
mouse. rhesus monkey and man in the ge-
netic fine structure of the major histocom-
patibility complex. It offers a model for 
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proving the hypothesis for the recogmtwn 
of "non self' and killing of allogt.>nic cells 
I Eijsvoogel ct al. 1972. Koch et a!. 1972 I 
by breeding "cross-over" dogs and obtain-
ing pairs of individuals with incompatibi-
lity only for one DL-group or one DL-
group + MLC determinant. Another in-
teresting possibility is to attempt to breed 
animals which are homozygous for the 
major histocompatibility complex, includ-
ing a DL-A and MLC regionls). Such a 
group of animals could provide a reference 
panel for the identification of "MLC de-
terminants" in random individuals and for 
the detennination of the influence of those 
factors on allografts of normal or malig-
nant tissue. The availability of transplan-
table. spontaneously occurring tumors in 
the dog I TVTI will provide a good model 
for further studies of tumor-host relation-
ships in an outbred species. 
The canine erythrocyte antigens CEA 1 
and 2 and possibly CEA 8 are of relevance 
in procedures involving multiple blood 
transfusions, since transfusion reactions 
have been reported to occur when incom-
patibilities existed for these antigens ( Swis-
her & Young 1961). Sensitization or en-
hancement in future organ recipients by 
blood transfusions ( Opelz et al. 1972) can 
now be investigated prospectively in the 
dog. The measurement of the immune re-
sponse of different animals to red and 
white cell antigens might also lead to the 
discovery of Immune Response ( IR) genes. 
a type of marker which is still unknown 
in the dog. The correlation between CEA 7 
and digestive tract group A awaits further 
elucidation. An interesting possibility is 
that two different genetic loci t:>xist, one 
for CEA 7 and one for digestive tract 
group A. which give rise to similar gene 
products. The other canine red cell anti-
gens may be useful for genetic studies, such 
as linkage studies and paternity cases. The 
biological significance and tht:> tissue distri-
bution of these antigens, except on ery-
throcytes) are as yet unknown. No relation-
ships were found between canine erythro-
cyte antigens and DL groups. Rubinstein 
et a!. ( 1968), however. have suggested that 
major histocompatibility antigens do occur 
on canine red cells. Experiments using a 
sensitive test and dog alloantisera of known 
DL specificity on canine red cells might 
resolve this interesting question. 
Certain molecular analogies were no-
ticed between the human and canine phos-
phoglucomutases (i.e. PGM 1 • PGM2 and 
PGM;1 ) suggesting a common evolutionary 
origin for the three forms of mutases in 
man and dog. Nevertheless, no measurable 
linkage was detected between the loci for 
DL-A and PGMa in male and female 
dogs. PGM~, which is generally not poly-
morphic in man, was also· not linked to 
DL-A. The serum protein and red and 
white cell enzyme markers can be very use-
ful in liver and bone marrow grafting for 
tests checking the presence or absence of 
donor types. Multiple transferrin zones in 
homozygotes have been described in other 
animals besides the dog (Manwell & Ann 
Baker 1970 ). This problem could be fur-
tl;ler investigated by examining the chem-
ical and physical properties of the protein 
moiety of purified Tf phenotypes. For the 
standardization of the Tf nomenclature, 
starch and agarost: gel typing should be 
compared. This is in progress in the de-
partment of human g-enetics of the Leyden 
University. 
The relationships between genetic mar-
kers I digestive tract group X, CEA 2, CEA 
8 and DL 12) and the occurrence of auto-
immune antibodies could \Veil be fortu-
itous. Mo"re studies are necessary to de-
te-rmine if there is a significant biological 
relationship between these genetic markers 
and the occurrence of autoimmune anti-
bodies. Some of the described polymorph-
isms might be examplt."s of genetic systems 
with a heterozygote advantage (as the 
sickle cell trait in man). The worldwide 
distribution, short generation time and 
existing pedigrees of some dog breeds could 
provide a rich source of material for the 
study of whether genetic drift or selection 
is the force maintaining a given genetical 
polymorphism I Harris 1971 ) . Earlier gene-
tic studies in the dog have been concerned 
mainly with macroscopical anatomic struc-
tures, coat colors and disease states (Little 
1957, Burns & Fraser 1966. Zweibaurn. 
personal communication). This group of 
markers has not been investigated in the 
workshop. It can be expected that future 
studies will attempt to correlate the pre-
sence of disease states and the various im-
munogenetic markers in the dog. Besides 
the genetical interest of such investigations, 
they might produce useful marker genes 
for special dog diseases and thus enable 
the identification of heterozygotes for re-
cessive disease genes. Phylogenetic relation-
ships between c:anids and canine paternity 
cases are other areas which can be further 
investigated with the immunogenetic sys-
tems described. 
Numerous other possible applications for 
the acquired insight into dog ge-netics were 
discussed during this workshop and sym-
posium. It was felt that conti..n.ued cooper-
ation would be profitable. The general 
consensus was that there was a need for 
another workshop. ]. W. Templeton agreed 
to assume the main responsibility for the 
organization of that second workshop. It 
will be held in November 1974 at the Uni-
versity of Oregon 1\1edical School. Port-
land, Oregon, l'.S.A. 
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DISCUSSION AND CONCLUSIONS 
6.1 INTRODUCTORY REMARKS 
In the preceeding chapters a gradually developing insight into the major 
histocompatibility complex of the dog has been documented. Most of the details 
of this complicated genetic region still have to be explored. Three different 
genetic systems have so far been identified as constituents of the canine major 
histocompatibility complex, i.e. two systems or segregant series of multiple 
alleles controlling antigens, which can be recognized serologically and probably a 
third polymorphic system whose products control reactivity in the mixed 
lymphocyte cultures. This chapter will discuss the now available knowledge and 
some speculations will be made on future developments. 
6.2 NOMENCLATURE 
A uniform and simple nomenclature is a prerequisite for proper communica~ 
tions between investigators and between investigators and interested laymen. 
The use of complicated signs for the factors under study will damage this 
communication. An attempt will be made to circumvent this fallacy by ex~ 
plaining the nomenclature decisions made on DL-A in detail. It is used by most 
workers in the field and agrees with most of the prerequisites for a useful 
notation system. Swisher (153) listed these prerequisites. 
Nomenclature symbols must be: 
(1) unambiguous 
(2) of simple format 
(3) compatible with usual modes of communication, written, printed, spoken 
and machinetransmitted 
( 4) translatable into the major scientific languages of the world 
(5) able to show, as far as possible, the historical development of the topic 
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( 6) in a form, easily used in data processing systems 
(7) made, so as to tolerate endless addition and deletion of symbols without 
necessitating alternative meanings for old symbols 
(8) defined in some ancillary document, scientific paper or organized lexicon. 
This will enable one to put rather less information into the symbol itself, to 
make the symbol an unequivocal index into some type of glossary and to 
concentrate the information in the latter site. 
The terms S.D. and L.D. have been introduced by Bach et a!. (114) and have 
been explained in chapter 1 (1.3.1 and 1.3.2). In this way major histocompati-
bility structures can be divided into ones which are serologically defined (S.D.) 
and ones which control lymphocyte reactivity in mixed cultures (lymphocyte 
defined or L.D.). The exact role of either S.D. or L.D. determinants in the 
recognition of "foreign" (allogeneic) tissue is not known. An attractive hypo-
thesis, put forward by Van Rood (96), and briefly discussed in chapter I (1.3.2) 
assumes that L.D. structures control the sensitization phase of the immune 
response of the recipient and S.D. structures the effector or destruction phase of 
this response. Extrapolating from the human data, which led to the formulation 
of this hypothesis one might anticipate that in dogs too, L.D. and S D. structures 
would both play their separate role in the recognition and destruction of foreign 
tissues. Therefore, it would be unjustified to limit a common nomenclature for 
factors of the canine major histocompatibility complex DL-A to the serological-
ly defined structures, although they are "historically speaking" older than the 
still insufficiently analysed lymphocyte defined structures. In accordance with 
the proposal of Elkins and Bach for mice (128), the term DL-A has been applied 
since the publication of the paper reprinted as chapter 5 in this thesis to all the 
three different systems so far identified (2 S.D. and 1 L.D. system). In this term 
D stands for dog, L for leucocyte; A is to indicate that this complex carries the 
nwjor histocompatibility information and that it was the first genetic region to 
be discovered, which controls leucocyte antigens. Genetic systems, which will be 
identified on dog leucocytes in the future should thus be labelled DL-B, DL-C 
etc. Two nomenclature decisions had to be made for the three systems of the 
DL-A complex (1) name/symbol for locus, (2) name/symbol for alleles of 
different loci. The two S.D. loci have been labelled first series and second series, 
the L.D. locus has been called M.L.R. (mixed lymphocyte reactivity) locus. The 
alleles of the three systems can be given a discrete number from 1 to infinite. It 
has been proposed to reserve numbers 149 for S.D. alleles and 50-100 for L.D. 
alleles (Grosse - Wilde et a!., manuscript in preperation). The prefix DL-A or DL 
can be used in front of the chosen number (see chapter 5). DL-A will be used 
when definite international agreement has been reached upon the recognition of 
a major histocompatibility structure. Before this has been achieved DL should be 
used for specificities which are recognized by many different laboratories, but 
whose analysis has not been completed yet. Locally discovered and recognized 
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specificities should be given a temporary local designation, until they are 
subjected to an international comparison test. For this purpose one could use for 
example the first letter of the home city of the investigator, followed by a 
number. If these nomenclature proposals are accepted, an international body of 
experts should be selected to evaluate periodically labels can be given to the 
emerging new factors (153). This committee should publish every two or three 
years an updated version of a list of all labels with a thorough description of the 
corresponding factors (see 8 of list of Swisher's prerequisites for a proper 
nomenclature). A successful cooperation of this sort has been achieved for 
human (e.g. 1), primate (116) and canine histocompatibility testing (see chapter 
5). Every two years workshops are organized, in which the functions of the 
above mentioned "board of international experts" are fulfilled. The extensive 
treatment of nomenclature problems in this paragraph was inspired by the 
confusion that immunogenetical symbols usually engender and the hope that 
this unnecessary chaos can be circumvented in the field of dog histocompati-
bility by the consequent use of a sensible nomenclature. 
6.3 POSITIONS OF SYSTEMS OF DL-A COMPLEX 
Figure 6.1 gives the most propable relative positions of the three systems so 
far identified. The recombination frequency between 1st. and 2nd. S.D. series 
was estimated to be around 0.7% (chapter 4). 
A rough estimate of the crossingover frequency between 2nd. S.D. series and 
M.L.R. can be made (around I% or lower) on the basis of still unpublished 
results of Van den Tweel and coworkers. The evidence for the given sequence 
has been discussed in chapter 5 and originates from only two families with 
crossovers in the DL-A complex. Obviously more such families have to be 
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Close linkage can be arbitrarily defined as the occurrence of different bits of 
genetical information on the same chromosome, which are separated by the 
event of crossing over with a frequency of less than 2%. One has, however, to 
keep in mind, that even between linked loci with this low recombination 
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frequency at least 250 genes must be located (121). The genes located between 
the three described DL-A systems could be related to the major histocompati-
bility complex. There is evidence available in other species that at least some of 
them are. In mice the Ss-Slp region, which is located between the two S.D. loci 
(see figure 6.3) was recently reported to be involved in the production of a 
substance of the complement system. The link of complement with immuno-
logical functions as graft rejection is evident. 
In chapter one (1.3.3) other genetical systems have been discussed, which were 
found to be linked, to the M.H.C. in mice (72), guinea pigs (65), rats (46), rhesus 
monkeys (11) and possibly man (66), the socalled Immune response or Ir 
systems. In mice, no recombination has been observed so far between the MLR 
locus of the major histocompatibility complex of this species and the Ir-1 locus 
(115, 145). This lead to the hypothesis that M.L.R. determinants are products of 
Ir genes since both M.L.R. and Ir structures play probably a role in the 
recognition phase of the immune response (120). More insight into the mode of 
action of both structures is needed to allow a verification of this hypothesis. 
This matter will be further discussed in the paragraph on the possible biological 
significance of the M.H.C. (6.5 .3). 
6.4 THE NUMBER OF S.D. AND L.D. LOCI IN A MAJOR IDSTOCOMPATI-
BILITY COMPLEX 
6.4.1 The number of S.D.loci 
The existence of two S.D. loci in the M.L.C. has been challenged. Histocom-
patibility studies have generally presumed antibodies to be complex and antigens 
to be simple. However, it is a truism that when antisera are used to define 
polymorphic antigens, one starts with two unknowns, i.e. antisera and antigens. 
It was illustrated by Hirschfield in 1965 (136) that different conclusions can be 
reached in a genetic analysis of antigen-antibody relationship depending on the 
bias of the investigator. Thus a different picture of the number ofSD. parts of 
the major histocompatibility complex might be obtained, when other a priori 
assumptions are made (e.g. simple antibodies and complex antigens). Hirschfield 
identified two different starting points for analysis, opposite extremes of a 
whole scale of possibilities, neither of the two necessarily representing the true 
relationship of antigen and antibody. The first approach was labelled simple-
complex since it assumes the antibodies to be simple and the antigens to be 
complex (consisting of more than one antigenic determinant). The second 
approach was given the name of complex-simple. Here one assumes the anti-
bodies to be complex (one antibody can "crossreact" (see also 1.3.1) with two 
different antigens) and the antigens to be simple. Recently Klein (142) illu-
strated and reiterated this point for serological histocompatibility studies in 
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mice. The two different principles of analysis are shown in a modified version of 
a figure from Klein's paper (figure 6.2). In the figure a schematic illustration of 
the two models is given. In the first model two different antigens exist, which 
have a one.to·one relationship with the two antisera. It can be seen that in the 
second model antiserum A also reacts with antigens of cell Y, which fit antibody 
A, although less well than antigens from cell X. Different conclusions are 
reached in the two models on the presence of antigens and antibodies, as is 
evidenced by the last two columns in figure 6.2. In reality either of the two 
extremes, or a situation in between, in which some of the antigens and some of 
the antibodies are complex (a complex-complex model) might be prevelant. The 
important point here is that it cannot be decided, which of the alternative 
models is the most realistic, without detailed information on the biochemical 
structure of the antigens involved. Due to technical difficulties the exact chemi· 
cal nature of major histocompatibility antigens is not yet known in any species 
(149). Genetic studies of major histocompatibility S.D. antigens have mainly 
used the complex-simple model with the exception of older studies in mice 
(152). 
1. Setologiool potterno 2. Model used For 3. Sohemotio 4. Nomenclature 
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The preference for the complex-simple model for analysis is not completely 
correct, since it might not represent the best approximation of reality. It was 
demonstrated, however, to be an efficient and relatively simple way of describ· 
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ing and explaining commonly found reactivity patterns of antisera in men, mice, 
rhesus monkeys and dogs. Moreover biochemical (126) and immunofluorescent 
studies (146), have revealed the probable existence of at least two different 
molecules carrying S.D. specificities. However, several authors (113, 118, 124) 
have suggested that each S.D. locus, consists of subunits, each coding for a 
separate part of the major histocompatibility structure involved. Arguments in 
favour of this new hypothesis are: 1. it does not have the complex-simple bias, 2. 
sera which fail to suppo~ the two loci theory are commonly neglected as too 
complicated to explain. Both points can be solved theoretically with the as-
sumption of two loci consisting each of several subunit. As already mentioned, 
the true and final picture of the detailed structure of the S.D. part of a M.H.S. 
will not be available until after a detailed biochemical characterisation of the 
antigens involved. Till that time the two loci concept will be a useful but still 
unverified model. Recently the probable existence of a third S.D. locus in man 
was reemphasized (141). In other mammals no more than two S.D.loci are still 
commonly thought to be present. 
6.4.2 The number of L.D. loci 
Not only the S.D. part of the M.H.C. might be more complex than the picture 
given in figure 6.1, since also the M.L.R. region might be more complicated. 
Eijsvoogel et al. (131) have obtained results in human mixed lymphocyte 
cultures, which they tentatively attributed to the effect of a second, weaker 
M.L.R. locus, in between the I st. and 2nd. S.D. series of the human histocom-
patibility complex. Bainer et al. (117) have in their investigations of the M.L.R. 
locus of rhesus monkeys described several results, which could not be explained 
by one M.L.R. locus alone. Festenstein and coworkers (132) have identified in 
mice a second genetic region, with an important influence on M.L.R. on a 
chromosome different from the one which carries the M.H.C. in this species. It 
can thus be concluded from these reports, that in several species more than one 
genetic system influences reactivity in mixed lymphocyte cultures. However, in 
all species so far investigated there is at least one locus with a major influence 
which appears to be linked to the S.D. part of the M.H.S. (see also next 
paragraph). Also in dogs data have recently become available indicating that 
more than one M.L.R. system does exist in this species (Van den Tweel, personal 
communication). Summarizing 6.4 it can be said that neither the definitive 
number of S.D.loci, neither the number of L.D.loci has been found. 
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6.5 FUNCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX (M.L.C.) 
6.5.1 Similarities of mammalian M.H.C.'s and occurrence of M.H.C.'s in non 
mammalian species 
Notwithstanding the still unsolved problems of the finer structure ofM.H.C.'s 
in all species) a study of the literature reveals that mammals have very similar 
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Major histocompatibility complex of four different mammalian species. 
Terms L.D., S.D. and Ir are explained in text. 
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figure 6.3, the data are depicted for the major histocompatibility complex of 
mice (142), men (32), rhesus monkeys (10, 11), and dogs (this thesis). To obtain 
the full story behind the figure for each species, the reader is advised to consult 
the given references. All species appear to have at least two S.D. loci and one 
M.L.R. locus and in those species in which Ir genes have been defined, at least 
some of theIr systems appear to be linked with the M.H.C. Exact mapping data 
for lr genes are not yet available for man and rhesus monkey, which is the reason 
for the question marks in the figure. Their presence has not been ascertained yet 
in dogs. Clearcut evidence for serological and/or biochemical similarities in 
M.H.C. structures of different species has not been found, with the exception of 
men and chimpanzees (9, 12, 30) and foxes and dogs (chapter 5). Vague 
indications for serological similarities of S.D. antigens of man and mouse have 
been found (125). Less information is available on M.H.C.'s in other mammalian 
species, not included in figure 6.3 (as rats, rabbits and guinea pigs). One should, 
however, keep in mind, that M.H.C.'s not only occur in mammals. Chickens also 
appear to posses one (I 37) and recently evidence has been found suggesting the 
existence of a M.L.R.locus in the amphibian xenopus laevis (148). 
6.5.2 Function in transplantation immunology 
Different functions for L.D. and S.D. genes 
The important role of the M.H.C. in tissue transplantation has been clearly 
established in all the mammalian species investigated so far. 
The earlier mentioned hypothesis, which can be found in the papers of Van 
Rood (96) and Eijsvoogel eta!. (I31), supposes that in transplant rejection L.D. 
and S.D. structures have different functions, which are related to the phase of 
the recipient's immune response. In phase one, (sensitisation phase) the recipient 
would recognize and be sensitized for the allogeneic material through the 
difference between the L.D. products of its own and those of the donor. In 
phase two (destruction phase) the recipient's immune system attacks the donor 
cells. Antigens controlled by the two S.D. loci serve as targets for this attack. 
Antigens of different S.D. series might not be of the same importance as targets. 
A difference in effect has been observed in mice (I35), man (53, 13I) and 
possibly dogs (Westbroek et al. unpublished observation). K, Four and second 
series antigens appear to have a greater influence on graft survival than D, LA 
and first series antigens. Grafts which differ forK, four or second series antigens 
with their recipients survive shorter than those which differ only for the D, LA 
or first series antigens. In man this effect was most clearly demonstrated in 
allograft recipients, which had received bloodtransfusions and subsequently 
produced antibodies against leucocyte antigens before kidney transplantation 
(53). This difference in importance of antigens of the two S.D. series cannot be 
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explained yet. It might be due to a difference in density in the cell membrane (a 
quantitative difference). A qualitative difference between antigens of different 
series is another possible explanation. 
Not only graft survival, but also graft histology and function appear to be 
influenced by the differences between donor and recipient for the M.H.C., 
Westbroek et al. (155) have shown that kidney grafts exchanged between DL-A 
identical sibs show biochemical and histological patterns of rejection different 
from those observed in grafts exchanged between DL·A non identical sibs. 
Another property of the M.H.C. is its influence on the effect of an immuno-
suppressive agent. For example de Gruyl et al. (134) have documented that a 
particular batch of ALS had a greater influence on pancreatic allograft survival 
in partially matched related DL-A donor-recipient pairs than in DL-A totally 
mismatched, unrelated donor-recipient pairs. The same has been shown in small 
bowel and kidney allografts (Rothengatter et a!. (150), Obertop unpublished 
observation). 
Results in small rodents have shown that the phenomena of enhancement and 
tolerance (for a definition of these terms see (138) and (151) respectively) are 
more easily produced in host-donor combinations, which differ for minor 
histocompatibility antigens only. Preliminary results of Jeekel et al. (139) 
suggest that the same holds for outbred animals e.g. dogs. Their studies, which 
are still in progress, seem to indicate that it is necessary for the evaluation and 
predictable production of enhancement in dogs to determine and minimize the 
M.H.C. differences between donor and recipient. 
In summary, it has become clear that the effect of the M.H.C. similarities or 
differences can be noted not only in graft survival, but in many ways. An exact 
definition of the role of the different systems of the M.H.C. in transplantation 
biology is still lacking. Some indications for differences in the role of S.D. and 
L.D. structures in transplant rejection have been found. 
6.5.3 Function in biology 
The search for a biological function ofM.H.C.'s has been discussed in chapter 
one. It was mentioned there that no precise function has yet been identified. 
Suggestive evidence for an "immunological" rOle in biology has, however, been 
found. In an earlier paragraph (6.5.1) and figure 6.3 it was shown that mamma-
lian M.H.C.'s resemble each other. One of the traits in common is the existence 
of close linkage between at least three systems with related functions. It is still 
unknown (123), whether the observed linkage between Ir genes and the major 
histocompatibility complex in several mammalian species is an indication of 
some functional relationship between the two. Several hypotheses on the bio-
logical function of Ir genes and histocompatibility assume that this is in fact the 
case (120, 122, 140). Experiments of Green et al. (133) are compatible with but 
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do not give conclusive evidence that there is a relationship between Ir gene 
products and S.D. major histocompatibility antigens, at least in vitro. Ohno 
(147) has, however, stressed that linkage per se does not indicate a functional 
relationship, since some functional related genes are linked, while others are not. 
More data are needed to improve our understanding of the relationships between 
the cluster of closely linked genetic systems which have been discussed in this 
thesis. The fact that important diseases have been shown to be related to the 
major histocompatibility complex and/or lr-systems (see 1.3.3), is the main 
rationale for the many extensive studies, which are being done now in that 
direction. 
6.6 DISCREPANCIES BETWEEN RESULTS OF HISTOCOMPATIBILITY 
TESTING IN RELATED COMPARED TO UNRELATED DONOR RECIPIENT 
PAIRS 
In man (53) and rhesus monkey (127) it was found that typing and matching 
donor and recipient for S.D. antigens was not as effective in prolonging graft 
survival, when donor and recipient were unrelated, compared to the clear cut 
improv'ement in survival of S.D. matched grafts of related donors. In Beagles 
transplantation experiments have been performed, by Westbroek and his col-
leagues, in related and unrelated donor recipient combinations, which were 
typed for serological DL-A antigens (154, and Westbroek et al. unpublished 
observations). Figure 6.4 shows the survival times of their different experimental 
groups. It is clear from the figure that in this model typing does have a 
pronounced effect on survival times of organs from unrelated, DL-A identical, 
donor recipient pairs. Two questions arise on the basis of the above mentioned 
data 
(1) What is the reason for the difference between related and unrelated donors' 
(2) Why do dogs appear to do better than primates, when organs from unrelated 
but S.D. compatible donors are used for grafting? 
Question (1) has been discussed in chapter one. Briefly the best available answer 
at the moment is that besides S.D. determinants, L.D. determinants and, perhaps 
other genetically controlled structures (Ir gene products') of a M.H.C., are also 
important for graft survival. 
In related donor recipient pairs, identity for S.D. antigens will generally also 
mean identity for the other important M.H.C. parts, since crossing over in the 
M.H.C. region is rather infrequent. In unrelated donor recipient identity for S.D. 
antigens will not necessarily imply identity for the other parts of the M.H.C. 
region. The occurrence of linkage disequilibrium between parts of the M.H.C. will 
nevertheless cause a higher frequency of identity for the total of M.H.C. 
information in unrelated donor recipient pairs, which are S.D. identical than in 
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no. of animals mean survival 
tested time(S.E.} 
7 27.8 (13.2} 
12 15.6 (7 .8} 
13 43.0 (12.5) 
8 27.5 (16.2} 
10 15.3 (13.2) 
• 45.3 (19.9} 
days 
Survival times of DL-A S.D. compatible grafts from unrelated donors, compared to survival 
times of DL-A identical grafts from related donors. 
10% of S.D. identical unrelated donor recipients pairs have been found to 
produce low or even negative responses in mixed lymphocyte cultures, while in 
S.D. nonidentical combinations only a very occasional low or negative response 
is found (131, Bainer, unpublished observation). This would explain why some-
times an improved survival can be found with the use of unrelated donors typed 
for S.D. antigens, since individuals with identical S.D. structures would have a 
higher chance of being identical for L.D. structures too. Although this explana-
tion is attractive, it has yet to be corroborated by allografting in the following 
experimental groups of unrelated donor recipient pairs. 
a. L.D. identical, S.D. identical combinations. 
b. L.D. identical, S.D. non-identical combinations. 
c. L.D. non-identical, S.D. identical combinations. 
A comparison of the survival times in these groups should reveal the influence of 
L.D. matching on graft survival and whether other structures different from L.D. 
and S.D. may also play a role. The first data related to this subject have come 
from Koch et al. (143). They seem to indicate that M.L.C. responses and thus 
L.D. determinants are important. The possibility that still other structures of the 
M.H.C. play an additional role in the determination of graft survival cannot be 
excluded. 
For question (2) (the reason for a greater efficiency of S.D. typing in unrelated 
canine donor recipient pairs, when compared to primate donor recipient pairs) 
the three, most evident, possible answers will be discussed here. A first, simple, 
explanation would be a limited amount of genetic variation in the Beagles used 
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by Westbroek et al., due to inbreeding. They were unrelated as far as their 
pedigrees go (2·3 generations), but could have had common ancestors before. 
Unrelated dogs would in fact be related, and thus explain the discrepancy 
between dogs and primates. The explanation does not hold for the data reported 
by Epstein et al. (129) on dog bone marrow grafting, in which donor and 
recipient were in almost all cases of different breeds. A beneficial effect of an at 
that time still limited S.D. typing and matching could nevertheless be demon-
strated. 
A second explanation could be a lower degree of polymorphism of the M.L.C. 
locus in dogs than in primates. This would increase the possibility of two . 
unrelated dogs having S.D. as well as L.D. structures of the M.H.C. identical, 
when only the S.D. antigens are being matched. When identify for S.D. and L.D. 
would be better for graft survival than identity for S.D. alone this would supply 
the answer asked for. Data reported by Meera Khan et al. ( 144) would support 
the second explanation. They described that only 4 out of 24 different enzymes 
were polymorphic in dogs. In other species commonly a higher percentage of 
polymorphic enzyme systems have been found. When a lower number of genetic 
systems in dogs is polymorphic or when less alleles are present in an average 
polymorphic genetic system, this could be explained by the assumption of a 
so-called bottle neck, or founder effect (see 21 ). Periods might have existed in 
dog history, in which the number of mating individuals per area was limited. 
This would have caused a loss of genetic variability. This holds a fortiori for a 
special dog breed (such as the Beagle), where the number of mating animals is 
limited by the desire of their owners to breed champions. For this purpose only 
a limited number of "top quality" sires. and bitches are allowed to breed. 
Arguments against this limited amount of genetic variation in dog are that 
Beagles were found to show marked polymorphism for S.D. determinants of the 
DL-A complex (see chapter 4) and were in Hardy Weinberg equilibrium for these 
antigens (chapters 3 and 4). This also excludes recent severe inbreeding as a 
source of limited genetic variation, but does of course not supply an answer for 
the possible loss of variability .through the presence of a bottle neck or founder 
effect for genetic systems other then the S.D. series (as M.L.R.). Another 
argument against a limited amount or loss of genetic variation in dogs is the 
well-known great diversity of this species for mainly polygenically determined 
traits such as body size, coat colour, coat texture etc., although some of the 
more extreme variations have undoubtedly been produced artificially by the 
selection of the dedicated dog breeders for the traits in question. Ultimately the 
determination of the frequency of M.L.C. negative combinations in unrelated 
dogs will show whether there is in fact a low degree of polymorphism for this 
genetic information in dogs. Preliminary experiments of Van den Tweel (perso~ 
nal communication) indicate that the precentage dog pairs, which is non reactive 
in unilateral M.L.C.'s is approximately 5%. This shows that the M.L.C. system 
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would be as polymorpltic as the S.D. systems of the canine major histocompati-
bility complex. This amount of polymorphy would be sufficient to cause 
rejection of the majority of S.D. matched organs from unrelated donors, if L.D. 
structures are indeed important in that respect. 
The third and at the present most likely explanation for the found differences 
between dogs and primates is suggested by still other results of canine M.L.C.'s 
from Van den Tweel and coworkers. They found a very !Ugh percentage of 
M.L.C. negative donor recipient pairs in unrelated S.D. identical pairs of mongrel 
dogs i.e. ± 50%, which is much higher than the percentage found in primates in 
the equivalent situation, i.e.± 10%. This can be explained by a ltigher degree of 
linkage disequilibrium between L.D. and S.D. structures of the canine major 
ltistocompatibility complex. Tltis outspoken linkage disequilibrium might for a 
yet undeternrined part be caused by the earlier mentioned founder effect. 
A !Ugh percentage of unrelated individuals wltich are identical for S.D. as well as 
L.D. parts of the M.H.C. in dogs is very useful for further studies, since these 
combinations are difficult to come by in other species. Moreover the availability 
of several dogs homozygous for L.D. alleles ((29) and Grosse-Wilde, personal 
communication) will enable a relatively easy identification of donor recipient 
pairs, wltich are L.D. identical but S.D. non identical. Thus all the host-donor 
combinations relevant for a better evaluation of the influence of matching on 
graft survival in unrelated donor-recipient pairs can be found in the dog. 
6.7 SUGGESTIONS FOR FURTHER EXPERIMENTS 
The experimental usefulness of dogs needs hardly any explanation. Surgeons 
commonly use and will use dogs in their laboratories. The size, temperament and 
availability of dogs are important reasons for this preference. 
A further exploration of the M.H.C. of the dog is therefore warranted. Ideally 
the knowledge of DL-A should reach a level comparable to the level of HL-A 
knowledge, so that feasibility studies can be performed in dogs, instead of in 
humans. This can be exemplified by the unwarranted application of enhance~ 
ment in human kidney transplantations (119), in which recipients have received 
anti donor antisera. Optimal conditions for the induction of tolerance or 
enhancement in outbred animals still need to be defined. Studies in e.g. dogs or 
other non~human outbred species should have preceded the clinical studies 
mentioned. The preliminary results of Jeekel et a!. (139) have underlined tltis 
need. 
Not only the transplant surgeon will benefit from a further exploration of the 
DL-A complex. The factors determining susceptibility to common diseases might 
be better defined, if further studies do indeed show a relationship between Ir 
genes and the DL-A complex. Further genetic studies of DL-A would benefit 
tremendously from an exact biochemical determination of its gene products. 
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This will be a formidable task, in the light of the great difficulties encountered in 
similar studies in other species. A list of other problems which need to be solved 
soon for further progress in dog histocompatibility studies can be constructed 
from the preceeding chapters. 
This list includes 
(1) a closer look at canine L.D. structures. Suggestions for a population analysis 
of these factors have been given. 
(2) investigations into the possible presence and linkage relationships of Ir genes 
in dogs. Recently such studies have been initiated. 
(3) allotypes for immunoglobulins have been defined in most laboratory ani-
mals but are not yet known in dogs. 
The studies described in this thesis were started in the hope that eventually the 
dog could serve as an experimental model to test new concepts in immunobio-
logy in outbred animals before application in humans. Clearly not enough has 
been achieyed fully to attain this goal. A better definition of the experimental 
subject still needs to be achieved. Future studies and a continuation of the 
internal cooperation, which has been initiated in this field (see chapter 5) will 
almost certainly achieve this lofty ambition. For the purpose of experimental 
surgeons an already fair degree of definition of the experimental subject has 
been reached. ln the light of the many advantages of dogs it is to be wished, that 
further progress in dog immunogenetics will provide an experimental animal 
with an even greater applicability. 
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APPENDIX 
One stage micro·cytotoxicity test. 
This test is a variation of the methods described by Kissmeyer·Nielsen and 
Kjerbye 1967, Boyum 1968, van Rood et al. 1970. 
Cell separation. 
1. Sec of blood is taken in heparine from the vena cephalica anterior or the vena 
jugularis. The heparine should be free of toxicity for lymphocytes (e.g. 2 
drops of thromboliquine of Organon Oss, The Netherlands, the equivalent of 
approximately 500 l.U.). 
2. Add a trace of carnonyl iron powder (General Aniline and Film Corporation, 
140 West 51 St., New York N.Y. 10020,341 product code 1-1-63763). 
3. Swirl for 10' at 37° C in waterbath. 
4. Add 5% dextran (M.W. 200.000; Poviet, Amsterdam) in saline. Let mixture 
sediment for 301 in upright position at 37°. C in waterbath. 
5. Remove supernatant. Layer ± 1.5 ml of supernatant over 1 ml of ficoll-iso-
paque mixture. This should be done carefully without disturbing the inter-
phase. Tubes should be about 11 mrn in diameter and about 80 mm long. 
Preparation of Ficoli-Isopaque solution: Isopaque 440 ( 440 mg 1/ml. pro 
injection; Nyegaard 10 AS, Oslo, Norway). Ficoll Mw light scattering ca. 
400.000: Pharmacia Uppsala, Uppsala, Sweden. The final mixture consists of 
10 parts 33.9 percent isopaque and 24 parts 9 percent fico!!. Final density 
should be 1.077 g/ml. 
6. Spin 15' at 1000 g. Remove lymphocytes from interphase, take care to 
remove as little Ficoll-lsopaque as possible. Wash twice in Hanks B~S. Spin 
cells down at 400 g for s'. 
7. Add 4 drops of undiluted fresh whole rabbit serum. Count number of 
lymphocytes and adjust to approximately 6000/mm3 by addition of more 
rabbit serum. The rabbit serum .should be screened for "naturally occurring" 
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antidog lymphocytotoxins and complement activity. This can be done by 
testing lymphocyte samples of 5 different dogs with rabbit serum and with 
inactivated dog alloantisera, which are known to react positively and negative-
ly with the cell samples to be studied. Only sera from rabbits with no 
"natural occurring" antibody activity against dog lymphocytes and a with a 
good complement activity should be pooled and used as complement source. 
Test. 
I. Trays (Coates Logos, Rabekk gt. 3, Moss, Norway) are filled with paraffin. A 
nontoxic paraffin should be used (e.g. Medinol 195). I f.ll of the antisera are 
injected into the wells, under the Medinol oil with a Hamilton microsyringe. 
Before use antisera have to centrifuged at a high speed to remove the debri in 
the serum which will interfere with a proper reading of the test. 
2. Add I f.ll of lymphocyte suspension. Mix serum and cell suspension by gentle 
shaking. 
Incubate for 30' at 37° C. 
3. Mix 2% trypan blue in distilled water with an equal volume of I ,8% NaCI. 
Centrifuge mixture to remove particulate matter at 2000 g for 10' Add 0.5 f.ll 
of the dye to the cell serum mixture. 
4. Incubate for 30' at room temperature or for 10' at 37° C. After incubation 
place glass coverslip (Chance Microscope Cover Glasses 28 x 53 mm) over the 
droplets and press gently to spread droplets out. 
5. The test is read with an inverted microscope and scored by visual estimation 
of percent of cells, which have taken up the dye. 
score %dye uptake 
0 





Storage of trays pre filled with antisera at -20° C. 
Storage of whole blood for 2-3 days at 4° C before processing for cellsus-
pensions is possible. 
Boyum A. (1968) Separation of leucocytes from blood and bone marrow. Scand. J. Clin. 
Lab. Invest, 21 Suppl. 97. 
Kissmeyer-Nielsen F. and Kjerbey F.E. (1967) Lymphocytotoxic Microtechnique purifi-
cation of lymphocytes by flotation. Histocompatibility Testing 1967, pp. 381-387 
Munksgaard, Copenhagen. 
van Rood J.J., van Leeuwen A. and Zweerus R. (1970) The 4A and 4B antigens: Do they or 
don't they. Histocompatibility Testing 1970, pp. 93-103, Munksgaard, Copenhagen. 
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SUMMARY 
In chapter 1 an introduction into the field of histocompatibility is given. A 
historical survey of important landmarks in two different lines of research is 
used for this purpose, i.e. 1 . experimental transplantation of malignant cells and 
2. the determination of differences between individuals by serological methods. 
The second part of chapter 1 is devoted to the description of some of the 
current topics in histocompatibility research. In sequence are discussed the 
demonstration of the existence of major histocompatibility complex, cellular 
methods of measuring histocompatibility and the biological significance of 
histocompatibility. Chapters 2, 3, 4 and 5 have been published previously as 
separate scientific communications in which shorter descriptions of results are 
given, than in the commonly more elaborate thesis, not based on earlier pu-
blished results. For that reason chapter 1 has also been written as a guide to 
these latter chapters. 
Chapter 2 describes the production and evaluation of serological tissue typing 
reagents in dogs. The existence of a major histocompatibility system in dogs is 
demonstrated. Later this system will be promoted to a complex, since it appears 
to be more complicated than was primarily assumed (see chapters 5 and 6). 
In chapter 3 the first serologically defined antigens of the DL-A complex are 
described. Evidence for the existence of at least two series of multiple alleles 
controlling DL-A antigens is presented. 
Chapter 4 gives more information on the DL-groups of chapter 3 and adds 
several groups to those already known. Recombination between the two series is 
reported. Associations between DL-groups of different series in a dog population 
are documented, suggesting a fair degree of linkage disequilibrium between some 
alleles of the two series. An association between DL-7 and the disease leukosis 
is found. Further studies are needed to corroborate this. A survey of the survival 
times of different organs from donors matched for the major histocompatibility 
complex is given. 
Chapter 5 is the report of the first international Workshop of Canine Immuno-
genetics which was held in Rotterdam at the Medical Faculty of the Erasmus 
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University of Rotterdam, from November 5 - 17 in 1972. Previously described 
serologically defined DL-groups have been confirmed by other workers in the 
field. One new DL-group has been found on this occasion. The Rotterdam-
Leiden nomenclature has been accepted for further use until the next workshop. 
The conclusion has been reached that probably a third genetic system is present 
in the DL~A region, which controls reactivity in mixed lymphocyte cultures. 
Two serologically defined specificities, which occur on lymphocytes, but which 
are different from DL-A antigens, were identified. They are probably controlled 
by alleles of the same genetic system. Other markers such as red cell antigens, 
digestive tract groups, red and white cell enzyme polymorphisms and serum · 
protein polymorphisms have been investigated during the workshop. No evi-
dence for linkage groups in dogs has been obtained so far. The DL-A complex is 
thus still the only example of autosomal linkage available in the dog. 
In chapter 6 the results obtained are discussed and comparisons are made with 
the major histocompatibility complexes of other mammals. A system for DL-A 
nomenclature is proposed and explained. The possible functions of a major 
histocompatibility complex in transplantation immunology and biology in 
general are described. The many unknowns of the DL-A complex and its possible 
relation to other genetic systems, are listed. Discrepancies between results of 
histocompatibility testing in related and unrelated donor recipient pairs are 
given. A tentative explanation for differences in efficiency of matching for 
serologically defined antigens in dogs and primates is proposed. 
Finally the need for further experiments is emphasized and suggestions for the 
most urgent ones are made. 
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SAMENV ATTING 
In het eerste hoofdstuk van dit proefschrift wordt een korte inleiding gegeven 
van het onderwerp histocompatibiliteit. Een historisch overzicht van belangrijke 
ontwikk.elingen in twee verschillende gebieden van onderzoek wordt voor dit 
doe! gebruikt, 1. experimentele transplantatie van maligne gezwellen en 2. de 
serologische determinatie van verschillen tussen individuen. Het tweede gedeelte 
van hoofdstuk 1 is gewijd aan de beschrijving van enkele van de huidige punten 
van onderzoek op het gebied van de histocompatibiliteit. Achtereenvolgens 
worden behandeld het aantonen van het bestaan van een hoofdhistocompatiM 
biliteits complex, cellulaire methodes voor histocompatibiliteitsonderzoek en de 
biologische betekenis van histocompatibiliteit. 
Hoofdstukken 2 tot en met 5 zijn reeds als afzonderlijke wetenschappelijke 
artikelen gepubliceerd. De in deze publicaties gebruikelijke korte vorm van 
rapportage, verdient nadere uitleg voor de oningewijde. Daarom dient hoofdstuk 
1 tevens als een soort leidraad voor deze hoofdstukken. 
In hoofdstuk 2 wordt de produktie en evaluatie van serologische histocompa-
tibiliteits reagentia in honden beschreven. Het bestaan van een hoofd histo-
compatibiliteits systeem in de hond (DL-A) wordt aannemelijk gemaakt. Later 
(zie hoofdstuk 5 en 6) zal dit "systeem" gepromoveerd worden tot een "com-
plex", aangezien het gecompliceerder blijkt te zijn, dan aanvankelijk was ver-
ondersteld. 
In hoofdstuk 3 worden de eerste serologisch gedefinieerde antigenen van het 
DL-A complex beschreven. Het bewijs voor het bestaan van tenminste twee 
series van multiple allelen, die coderen voor DL-A antigenen, wordt geleverd. 
Hoofdstuk 4 geeft meer informatie over de DL-groepen van hoofdstuk 3 en 
voegt verschillende groepen toe aan de reeds bekende. Recomb ina tie tussen de 
twee series wordt gevonden. Een positieve correlatie tussen sommige antigenen 
van de twee series in een populatie van onverwante honden wordt gevonden. Dit 
suggereert het bestaan van linkage disequilibrium tussen de twee series. Bij het 
ziektebeeld leukosis word! DL-7 vaker aangetroffen dan verwacht, alhoewel deze 
resultaten nog bevestigd zullen moeten worden door verdere studies. Een over-
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zicht van de overlevingsduur van orgaantransplantaten van donoren, die identiek 
zijn voor het hoofd hlstocompatibiliteits complex, wordt gegeven. 
Hoofdstuk 5 is het verslag van de eerste internationale Workshop on Canine 
Immunogenetics die van 5 · 17 november I 972 gehouden werd aan de Medische 
Faculteit te Rotterdam. Eerder gedefinieerde DL groepen zijn bevestigd door de 
resultaten van de andere wetenschappelijke teams. Een nieuwe DL groep is 
gevonden tijdens de Workshop. De nomenclatuur van RotterdamMLeiden zal 
internationaal worden aangehouden op basis van de tijdens de Workshop beM 
reikte overeenkomst tot een volgende Workshop. De aanwezigheid van nag een 
derde genetisch systeem in het DL-A gebied word! aannemelijk gemaakt. Het 
verschilt van de reeds beschreven series van multiple allelen, die coderen voor 
serologisch herkenbare antigenen, en controleert de reactiviteit in gemengde 
lymfocytenkweken (mixed lymphocyte cultures). 
Twee antigenen die op lymfocyten voorkomen, doch niet tot het DL-A complex 
behoren, worden gevonden. Zij zijn waarschijnlijk allelen van een en hetzelfde 
genetische systeem. Andere genetische merkgenen, als bloedgroepen, tractus 
digestivus groepen, polymorphe erythrocytenM en leucocyten enzymen en serum 
protei"ne polymorphismen zijn ook tijdens de Workshop onderzocht. Geen 
aanwijzing voor nauwe koppeling tussen een van deze genetische systemen en 
DL-A is gevonden. Het DL-A complex blijft dus voorlopig het enige voorbeeld 
van autosomale koppeling in de hond. 
In hoofdstuk 6 worden de verkregen resultaten besproken en vergeleken met de 
beschikbare gegevens over histocompatibiliteit in andere dieren. Een uitgewerkt 
voorstel voor DLMA nomenclatuur wordt gedaan en verdedigd. De mogelijke 
functies van een hoofd histocompatibiliteitscomplex in de transplantatie imM 
munologie en de algemene biologie worden beschreven. Tevens worden de vele 
onzekerheden van het DL-A complex en zijn relatie met andere genetische 
informatie opgesomd. De verschillen in resultaten bereikt met weefseltypering ill 
verwante en onverwante donor-ontvanger combinaties worden opgesomd en 
uitgelegd. Een mogelijke verklaring wordt gegeven voor het verschil in effecti-
viteit van donorselectie met serologische methoden in honden en primaten. De 
noodzaak voor verdere experimenten wordt uiteengezet. 
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